CA1211118A - 7-oxo-4-thia-1-azabicyclo[3,2,0]heptane derivatives - Google Patents
7-oxo-4-thia-1-azabicyclo[3,2,0]heptane derivativesInfo
- Publication number
- CA1211118A CA1211118A CA000487761A CA487761A CA1211118A CA 1211118 A CA1211118 A CA 1211118A CA 000487761 A CA000487761 A CA 000487761A CA 487761 A CA487761 A CA 487761A CA 1211118 A CA1211118 A CA 1211118A
- Authority
- CA
- Canada
- Prior art keywords
- group
- compound
- solution
- nitrobenzyl
- give
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- WSHJJCPTKWSMRR-UHFFFAOYSA-N 4-thia-1-azabicyclo[3.2.0]heptan-7-one Chemical class S1CCN2C(=O)CC21 WSHJJCPTKWSMRR-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 83
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 25
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 15
- 239000002253 acid Substances 0.000 claims abstract description 14
- 239000000460 chlorine Substances 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 13
- 230000008569 process Effects 0.000 claims abstract description 9
- 230000007062 hydrolysis Effects 0.000 claims abstract description 8
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 7
- 230000009467 reduction Effects 0.000 claims abstract description 7
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000006303 photolysis reaction Methods 0.000 claims abstract description 5
- 230000015843 photosynthesis, light reaction Effects 0.000 claims abstract description 5
- 102000004190 Enzymes Human genes 0.000 claims abstract description 4
- 108090000790 Enzymes Proteins 0.000 claims abstract description 4
- 230000009471 action Effects 0.000 claims abstract description 4
- 238000006722 reduction reaction Methods 0.000 claims abstract description 4
- 125000000217 alkyl group Chemical group 0.000 claims abstract 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims abstract 3
- 125000003118 aryl group Chemical group 0.000 claims abstract 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 15
- 125000003342 alkenyl group Chemical group 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 239000000543 intermediate Substances 0.000 abstract description 3
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 abstract description 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 2
- OTTZHAVKAVGASB-UHFFFAOYSA-N hept-2-ene Chemical class CCCCC=CC OTTZHAVKAVGASB-UHFFFAOYSA-N 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 75
- 239000000243 solution Substances 0.000 description 70
- 125000006503 p-nitrobenzyl group Chemical class [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 41
- -1 alkali metal alkoxide Chemical class 0.000 description 37
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 35
- 239000000203 mixture Substances 0.000 description 34
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 28
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 28
- 238000006243 chemical reaction Methods 0.000 description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 25
- 239000002585 base Substances 0.000 description 22
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 19
- 239000000741 silica gel Substances 0.000 description 19
- 229910002027 silica gel Inorganic materials 0.000 description 19
- 239000002904 solvent Substances 0.000 description 19
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
- 229920000180 alkyd Polymers 0.000 description 16
- 150000002148 esters Chemical class 0.000 description 16
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 15
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 14
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 11
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 11
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 10
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 10
- 101150041968 CDC13 gene Proteins 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 9
- 239000012044 organic layer Substances 0.000 description 9
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 description 9
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 239000012267 brine Substances 0.000 description 7
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 7
- 125000000623 heterocyclic group Chemical group 0.000 description 7
- JESHZQPNPCJVNG-UHFFFAOYSA-L magnesium;sulfite Chemical compound [Mg+2].[O-]S([O-])=O JESHZQPNPCJVNG-UHFFFAOYSA-L 0.000 description 7
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 7
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 7
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 7
- 239000007858 starting material Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 229940113088 dimethylacetamide Drugs 0.000 description 6
- 125000005843 halogen group Chemical group 0.000 description 6
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 6
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 6
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 5
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 5
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 5
- 125000000753 cycloalkyl group Chemical group 0.000 description 5
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 5
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 125000006239 protecting group Chemical group 0.000 description 5
- 230000003595 spectral effect Effects 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- 235000019502 Orange oil Nutrition 0.000 description 4
- 241001307210 Pene Species 0.000 description 4
- 125000003710 aryl alkyl group Chemical group 0.000 description 4
- 239000012298 atmosphere Substances 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 150000002430 hydrocarbons Chemical class 0.000 description 4
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 4
- 239000010502 orange oil Substances 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 235000011181 potassium carbonates Nutrition 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 4
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical group Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Natural products OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 150000001340 alkali metals Chemical class 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 230000002140 halogenating effect Effects 0.000 description 3
- 230000026030 halogenation Effects 0.000 description 3
- 238000005658 halogenation reaction Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- 235000010265 sodium sulphite Nutrition 0.000 description 3
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 3
- VOLRSQPSJGXRNJ-UHFFFAOYSA-N 4-nitrobenzyl bromide Chemical compound [O-][N+](=O)C1=CC=C(CBr)C=C1 VOLRSQPSJGXRNJ-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- WLJVNTCWHIRURA-UHFFFAOYSA-N Heptanedioic acid Natural products OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 239000012300 argon atmosphere Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical compound O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N hexanedioic acid Natural products OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- ANYSGBYRTLOUPO-UHFFFAOYSA-N lithium tetramethylpiperidide Chemical compound [Li]N1C(C)(C)CCCC1(C)C ANYSGBYRTLOUPO-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000011736 potassium bicarbonate Substances 0.000 description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 2
- HFVMEOPYDLEHBR-UHFFFAOYSA-N (2-fluorophenyl)-phenylmethanol Chemical compound C=1C=CC=C(F)C=1C(O)C1=CC=CC=C1 HFVMEOPYDLEHBR-UHFFFAOYSA-N 0.000 description 1
- KYVBNYUBXIEUFW-UHFFFAOYSA-N 1,1,3,3-tetramethylguanidine Chemical compound CN(C)C(=N)N(C)C KYVBNYUBXIEUFW-UHFFFAOYSA-N 0.000 description 1
- SCZNXLWKYFICFV-UHFFFAOYSA-N 1,2,3,4,5,7,8,9-octahydropyrido[1,2-b]diazepine Chemical compound C1CCCNN2CCCC=C21 SCZNXLWKYFICFV-UHFFFAOYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- QVCUKHQDEZNNOC-UHFFFAOYSA-N 1,2-diazabicyclo[2.2.2]octane Chemical compound C1CC2CCN1NC2 QVCUKHQDEZNNOC-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- WVYIZGMCLSGZGG-UHFFFAOYSA-N 10-hydroxy-cis-12-octadecenoic acid Natural products CCCCCC=CCC(O)CCCCCCCCC(O)=O WVYIZGMCLSGZGG-UHFFFAOYSA-N 0.000 description 1
- SHXWCVYOXRDMCX-UHFFFAOYSA-N 3,4-methylenedioxymethamphetamine Chemical compound CNC(C)CC1=CC=C2OCOC2=C1 SHXWCVYOXRDMCX-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 1
- DUNKKIRUWZSMPT-UHFFFAOYSA-N 7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound OC(=O)C1=CSC2CC(=O)N12 DUNKKIRUWZSMPT-UHFFFAOYSA-N 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- 241000110847 Kochia Species 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M Methanesulfonate Chemical compound CS([O-])(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- 241000700110 Myocastor coypus Species 0.000 description 1
- OJGMBLNIHDZDGS-UHFFFAOYSA-N N-ethyl-N-phenylamine Natural products CCNC1=CC=CC=C1 OJGMBLNIHDZDGS-UHFFFAOYSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 125000005042 acyloxymethyl group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000005002 aryl methyl group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical group OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- HFNQLYDPNAZRCH-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O.OC(O)=O HFNQLYDPNAZRCH-UHFFFAOYSA-N 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 229910001919 chlorite Inorganic materials 0.000 description 1
- 229910052619 chlorite group Inorganic materials 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- QPJDMGCKMHUXFD-UHFFFAOYSA-N cyanogen chloride Chemical compound ClC#N QPJDMGCKMHUXFD-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000012973 diazabicyclooctane Substances 0.000 description 1
- 150000001990 dicarboxylic acid derivatives Chemical class 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- OREAFAJWWJHCOT-UHFFFAOYSA-N dimethylmalonic acid Chemical compound OC(=O)C(C)(C)C(O)=O OREAFAJWWJHCOT-UHFFFAOYSA-N 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- LJKNRSBEKUSSIE-UHFFFAOYSA-N hept-2-ene Chemical compound [CH2]CCCC=CC LJKNRSBEKUSSIE-UHFFFAOYSA-N 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- UPRXAOPZPSAYHF-UHFFFAOYSA-N lithium;cyclohexyl(propan-2-yl)azanide Chemical compound CC(C)N([Li])C1CCCCC1 UPRXAOPZPSAYHF-UHFFFAOYSA-N 0.000 description 1
- DWNRISLZVCBTRN-UHFFFAOYSA-N lithium;piperidin-1-ide Chemical compound [Li]N1CCCCC1 DWNRISLZVCBTRN-UHFFFAOYSA-N 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 235000012245 magnesium oxide Nutrition 0.000 description 1
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000006502 nitrobenzyl group Chemical group 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000005633 phthalidyl group Chemical group 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000003385 sodium Chemical class 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000003797 solvolysis reaction Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- NBNBICNWNFQDDD-UHFFFAOYSA-N sulfuryl dibromide Chemical compound BrS(Br)(=O)=O NBNBICNWNFQDDD-UHFFFAOYSA-N 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- IXZDIALLLMRYOU-UHFFFAOYSA-N tert-butyl hypochlorite Chemical compound CC(C)(C)OCl IXZDIALLLMRYOU-UHFFFAOYSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Abstract of the Disclosure Compounds of the formula IIa, IIb and IIc
Description
2 - JOE 82/S 001 The present invention relates to certain intermediates for the preparation of 7-oxo-4-thia-1-azabicyclo[3,2,0]-Hutton and Hutton derivatives, and to a process for their preparation.
7-Oxo 4-thia-1-a~abicyclo[3,2,0]heptane and 7-oxo 4-thia-1-azabicyclo[3,2,0~hept-2-ene penes have the following structures:
I owe Hutton Hutton Certain derivatives of these basic structures have antibiotic properties, see, for example, British Patent Applications Nos. 2 074 563, 2 042 520 and 2 013 674. There are, however, disadvantages in the methods proposed for synthesizing such compounds, for example, the low yields generally achieved, which are exacerbated by the isometric composition of the product: it is well known that certain stereochemistry in penes compounds is desirable as isomers having this stereochemistry are more biologically active than other isomers. Many of the processes proposed for the production of penes derivatives and their precursors do not give predominantly the desired isomers, and the search continues for more effective methods of synthesizing these structures.
The present invention provides a compound of the general formula It and its tautomer It H OH
COO COO
(It) (It) ~211~
7-Oxo 4-thia-1-a~abicyclo[3,2,0]heptane and 7-oxo 4-thia-1-azabicyclo[3,2,0~hept-2-ene penes have the following structures:
I owe Hutton Hutton Certain derivatives of these basic structures have antibiotic properties, see, for example, British Patent Applications Nos. 2 074 563, 2 042 520 and 2 013 674. There are, however, disadvantages in the methods proposed for synthesizing such compounds, for example, the low yields generally achieved, which are exacerbated by the isometric composition of the product: it is well known that certain stereochemistry in penes compounds is desirable as isomers having this stereochemistry are more biologically active than other isomers. Many of the processes proposed for the production of penes derivatives and their precursors do not give predominantly the desired isomers, and the search continues for more effective methods of synthesizing these structures.
The present invention provides a compound of the general formula It and its tautomer It H OH
COO COO
(It) (It) ~211~
- 3 - HOE 82/S 001 in which formulae R represents a carboxyl esterifying group removable by hydrolysis, photolysis, reduction, or en eye Ashley to give the free acid.
The term "a compound of the general formula I" and "a compound of formula I" are both used herein to denote a compound of the general formula Ian a compound of the general formula IBM or any mixture thereof. "A compound of formula II" is used to denote collectively compounds of formulae Ida, Jib and Tic. The terms "a compound of formula III" and "a compound of formula IV" are used analogously.
The present invention also provides a process for the production of a compound of the general formula I, which comprises treating a compound of the general formula Ida, Jib, or Tic 1 X Scorn X S
ROOT Sorb ROOT
(IIaj (Jib) DO
3 , p ROOT
(Tic) in which R is as defined above, R represents a chlorine or bromide atom, the radicals Ray and Rub, which may be the same or different, each represents an alkyd group having from 1 to 4 carbon atoms, I,,, Lo
The term "a compound of the general formula I" and "a compound of formula I" are both used herein to denote a compound of the general formula Ian a compound of the general formula IBM or any mixture thereof. "A compound of formula II" is used to denote collectively compounds of formulae Ida, Jib and Tic. The terms "a compound of formula III" and "a compound of formula IV" are used analogously.
The present invention also provides a process for the production of a compound of the general formula I, which comprises treating a compound of the general formula Ida, Jib, or Tic 1 X Scorn X S
ROOT Sorb ROOT
(IIaj (Jib) DO
3 , p ROOT
(Tic) in which R is as defined above, R represents a chlorine or bromide atom, the radicals Ray and Rub, which may be the same or different, each represents an alkyd group having from 1 to 4 carbon atoms, I,,, Lo
- 4 - HOE 82/S 001 especially a methyl or t~butyl group, an aureole group, especially a phenol group, or an aralkyl group, especially a bouncily group, and A represents a direct bond or the residue of a dicarboxylic acid, with a base.
The base used in the above reaction must be capable of splitting a sulphur-carbonyl bond in the compound of formula II and of bringing about ring closure. The base may be inorganic or organic, for example, ammonia, or an alkali metal (especially a sodium or potassium) carbonate bicarbonate, or hydroxide; a primary amine, for example, methyl amine, ethyl amine, aniline or benzylamine; an alkali metal alkoxide, for example, sodium methoxide; or a heterocyclic base, for example, having a Pea within the range of from 5 to 9, for example, imidazole or pardon or a substituted pardon, for example, an alkyd-, amino-, or alkylamino-substituted pardon, for example, 4-methyl- or 4-dime~lylamino-pyridine. Imidazole is particularly preferred.
The reaction is generally carried out in a solvent or delineate, the choice of which is wide, provided that it is inert under the reaction conditions. Examples of solvents and delineates are oxygenated hydrocarbons, for example, alcohols, for example, having up to 4 carbon atoms, for example, methanol and ethanol; ethers, for example, having up to 4 carbon atoms, for example, deathly ether, also twitter-hydrofuran and Dixon; kittens, for example, having up to 4 carbon atoms, for example acetone and methyl ethyl kitten; esters for example, methyl acetate and ethyl acetate; and asides, for example, dimethylformamide and dimethylacetamide; also chlorinated hydrocarbons, for example, chloroform, ethylene chloride and carton twitter-chloride; aromatic hydrocarbons, for example, Bunsen and Tulane; and other solvents, for example, asset-nitrite and nitromethane. A mixture of any two or more solvents may be used, and solvents are preferably used I
The base used in the above reaction must be capable of splitting a sulphur-carbonyl bond in the compound of formula II and of bringing about ring closure. The base may be inorganic or organic, for example, ammonia, or an alkali metal (especially a sodium or potassium) carbonate bicarbonate, or hydroxide; a primary amine, for example, methyl amine, ethyl amine, aniline or benzylamine; an alkali metal alkoxide, for example, sodium methoxide; or a heterocyclic base, for example, having a Pea within the range of from 5 to 9, for example, imidazole or pardon or a substituted pardon, for example, an alkyd-, amino-, or alkylamino-substituted pardon, for example, 4-methyl- or 4-dime~lylamino-pyridine. Imidazole is particularly preferred.
The reaction is generally carried out in a solvent or delineate, the choice of which is wide, provided that it is inert under the reaction conditions. Examples of solvents and delineates are oxygenated hydrocarbons, for example, alcohols, for example, having up to 4 carbon atoms, for example, methanol and ethanol; ethers, for example, having up to 4 carbon atoms, for example, deathly ether, also twitter-hydrofuran and Dixon; kittens, for example, having up to 4 carbon atoms, for example acetone and methyl ethyl kitten; esters for example, methyl acetate and ethyl acetate; and asides, for example, dimethylformamide and dimethylacetamide; also chlorinated hydrocarbons, for example, chloroform, ethylene chloride and carton twitter-chloride; aromatic hydrocarbons, for example, Bunsen and Tulane; and other solvents, for example, asset-nitrite and nitromethane. A mixture of any two or more solvents may be used, and solvents are preferably used I
- 5 - HOE US 001 in admixture with water, preferably a water-miscible solvent in admixture with 5 to 20 % (v/v) water, especially a mixture of Dixon and water, preferably 5 to 10 % (v/v) water.
The reaction is generally carried out at a temperature within the range of from 0 to 40C, preferably from 0 to 20C .
An esterified carboxyl group -COO is, for example, an ester formed with an unsubstituted or substituted aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, aureole, araliphatic, heterocyclic or heterocyclic-ali-phatic alcohol having up to 20 carbon atoms, or is, for example, s sill or Stanley ester.
R may represent, for example a straight or branched chain substituted or unsubstituted alkyd, alkenyl or alkynyl group having up to 18 carbon atoms preferably, up to 8 carbon atoms, and especially up to 4 carbon atoms, for example, a methyl, ethyl, n-propyl, isopropyl n-bottle, sec-butyl, iso-butyl, tert-butyl, n-pentyl, n-hexyl, ally, or vinyl group.
An aliphatic group R, especially a methyl group, may be substituted by a cycloalkyl, aureole or heterocyclic group, or R may itself represent a cycloalkyl, aureole or heterocyclic group.
A cycloaliphatic group R may have up to 18 carbon atoms and is, for example, a cyclopentyl, cyclohexyl or adamantly group. An aureole group may have up to 12 carbon atoms and may have two or more fused rings. An aureole group R is, for example, an unsubstituted or substituted phenol group, and an unsubstituted or substituted aralkyl group is, for example, a bouncily, ~-nitrobenzyl or bent-hydryl group.
A heterocyclic group may have one or more hotter-atoms, selected from oxygen, nitrogen and Selfware, and up to 14 atoms in total. A heterocyclic group is, for example, an oxygen-containing heterocyclic group, for example, a tetrahydropyranyl or phthalidyl group.
'I
I
The reaction is generally carried out at a temperature within the range of from 0 to 40C, preferably from 0 to 20C .
An esterified carboxyl group -COO is, for example, an ester formed with an unsubstituted or substituted aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, aureole, araliphatic, heterocyclic or heterocyclic-ali-phatic alcohol having up to 20 carbon atoms, or is, for example, s sill or Stanley ester.
R may represent, for example a straight or branched chain substituted or unsubstituted alkyd, alkenyl or alkynyl group having up to 18 carbon atoms preferably, up to 8 carbon atoms, and especially up to 4 carbon atoms, for example, a methyl, ethyl, n-propyl, isopropyl n-bottle, sec-butyl, iso-butyl, tert-butyl, n-pentyl, n-hexyl, ally, or vinyl group.
An aliphatic group R, especially a methyl group, may be substituted by a cycloalkyl, aureole or heterocyclic group, or R may itself represent a cycloalkyl, aureole or heterocyclic group.
A cycloaliphatic group R may have up to 18 carbon atoms and is, for example, a cyclopentyl, cyclohexyl or adamantly group. An aureole group may have up to 12 carbon atoms and may have two or more fused rings. An aureole group R is, for example, an unsubstituted or substituted phenol group, and an unsubstituted or substituted aralkyl group is, for example, a bouncily, ~-nitrobenzyl or bent-hydryl group.
A heterocyclic group may have one or more hotter-atoms, selected from oxygen, nitrogen and Selfware, and up to 14 atoms in total. A heterocyclic group is, for example, an oxygen-containing heterocyclic group, for example, a tetrahydropyranyl or phthalidyl group.
'I
I
- 6 - HOE 82/S 001 A Stanley group R may have up to 24 carbon atoms, for example, R may represent a Stanley group having three substituents, which may be the same or different, selected from alkyd, alkenyl, cycloalkyl, aureole, aralkyl, alkoxy and aralkoxy groups, for example, alkyd groups having up to 4 carbon atoms, for example, n-butyl groups, phenol and bouncily groups, especially three n- bottle groups.
A sill group R may also have up to 24 carbon atoms and three substituents, which may be the same or different, selected from alkyd, alkenyl, cycloalkyl, aureole and aralkyl groups, for example alkyd groups having up to 4 carbon atoms, for example, methyl and t-butyl groups.
Any group R that is capable of substitution may be substituted, for example, with a halogen atom, especially a chlorine or bromide atom, or a vitro group.
The group R may be removable by hydrolysis, by photolysis, by reduction or by enzyme action to give the free acid, or two or more methods may be used, for example, reduction followed by hydrolysis. A group R that may be removed readily without substantial degradation of the rest of the molecule is particularly useful as a carboxyl protecting group. Examples of esters that are readily split by reduction are arylmethyl esters, for example, bouncily, ~-nitrobenzyl, benzhydryl and tritely esters.
A Stanley ester, for example, a tri-n-butyl Stanley ester, may be split readily by hydrolysis, for example, by solvolysis, for example, using water, an alcohol, a phenol or a carboxylic acid, for example, acetic acid.
Certain ester groups may be split off by base hydrolysis, for example, acetylmethyl and acetoxymethyl ester groups.
There may be used an esterifying group that is removable under physiological conditions, that is to say, the esterifying group is split off in viva to give the free acid or the carboxylate, for example, an acyloxy-methyl ester, e.g. an acetoxymethyl or pivaloyloxymethyl ., .
)'"' ,,~ I
I
A sill group R may also have up to 24 carbon atoms and three substituents, which may be the same or different, selected from alkyd, alkenyl, cycloalkyl, aureole and aralkyl groups, for example alkyd groups having up to 4 carbon atoms, for example, methyl and t-butyl groups.
Any group R that is capable of substitution may be substituted, for example, with a halogen atom, especially a chlorine or bromide atom, or a vitro group.
The group R may be removable by hydrolysis, by photolysis, by reduction or by enzyme action to give the free acid, or two or more methods may be used, for example, reduction followed by hydrolysis. A group R that may be removed readily without substantial degradation of the rest of the molecule is particularly useful as a carboxyl protecting group. Examples of esters that are readily split by reduction are arylmethyl esters, for example, bouncily, ~-nitrobenzyl, benzhydryl and tritely esters.
A Stanley ester, for example, a tri-n-butyl Stanley ester, may be split readily by hydrolysis, for example, by solvolysis, for example, using water, an alcohol, a phenol or a carboxylic acid, for example, acetic acid.
Certain ester groups may be split off by base hydrolysis, for example, acetylmethyl and acetoxymethyl ester groups.
There may be used an esterifying group that is removable under physiological conditions, that is to say, the esterifying group is split off in viva to give the free acid or the carboxylate, for example, an acyloxy-methyl ester, e.g. an acetoxymethyl or pivaloyloxymethyl ., .
)'"' ,,~ I
I
- 7 -- HOE 82/S 001 ester, an aminoalkanyloxymethyl ester, for example, an L-glycyloxymethyl, L-valyloxymethyl or L-leucyloxymethyl ester, or a phthalidyl ester, or an optionally substituted 2-aminoethyl ester, for example, a 2-diethylamino-ethyl or 2-(1-morpholino)-ethyl ester.
Preferred esters are the p-nitrobenzyl, phthalid~yl, pivaloyloxymethyl, acetylmethyl and acetoxy-methyl esters.
A compound of the general formula Ida, Jib, or Tic is preferably produced by halogenating a compound of the general formula IIIa, IIIb or Icky, respectively, OH / OH
SHEA c~3 ROOT Sorb ROOT
(IIIa) (IIIb) OH
SO O
CLUE )~. So O
ROOT
Icky in which R, Ray Rub and A are defined as above, and R3 represents an alkyd group having from 1 to
Preferred esters are the p-nitrobenzyl, phthalid~yl, pivaloyloxymethyl, acetylmethyl and acetoxy-methyl esters.
A compound of the general formula Ida, Jib, or Tic is preferably produced by halogenating a compound of the general formula IIIa, IIIb or Icky, respectively, OH / OH
SHEA c~3 ROOT Sorb ROOT
(IIIa) (IIIb) OH
SO O
CLUE )~. So O
ROOT
Icky in which R, Ray Rub and A are defined as above, and R3 represents an alkyd group having from 1 to
8, preferably from 1 to 6, and especially from 1 to 4 carbon atoms, for example, an ethyl group, or an alkenyl group having up to 6 carbon atoms, especially an ally group.
r r I.
I
The halogenation of a compound of formula IIIa, IIIb or Icky is carried out with an agent capable of splitting a carbon-sulphur bond and introducing a halogen atom. Such agents are well known in the art and include, for example, molecular chlorine, molecular bromide, sulphuryl chloride, sulphuryl bromide, t-butyl hype-chlorite and cyanogen chloride.
The halogenating agent is generally used in an amount of from 1 to 2 mole equivalents, calculated on the compound I of formula III. The reaction is generally carried out at a temperature within the range of from -40 to +20C. The reaction is generally carried out in a solvent or delineate that is aprotic and is inert under the reaction conditions, for example, an ether, a hydrocarbon or a halogenated hydra-carbon, for example, Dixon, Bunsen, chloroform ormethylene chloride. A mixture of two or more solvents may be used. Examples of halogenating systems are: chlorine in chloroform and, especially, chlorine in Bunsen and t-bottle hypochlorite in Bunsen. In the latter two cases, the temperature is preferably from 5 to 20C, and especially from 5 to 10C.
A compound of formula IIIa, IIIb, or Icky is prefer-ably produced by removing the protective group from a compound of formula Ivan Ivy or Ivy, respectively, o'er or SHEA I sR3 SHEA - C, SR3 N Scorn N
ROOT Sorb ROW S
(Ivy) (Ivy) I lull
r r I.
I
The halogenation of a compound of formula IIIa, IIIb or Icky is carried out with an agent capable of splitting a carbon-sulphur bond and introducing a halogen atom. Such agents are well known in the art and include, for example, molecular chlorine, molecular bromide, sulphuryl chloride, sulphuryl bromide, t-butyl hype-chlorite and cyanogen chloride.
The halogenating agent is generally used in an amount of from 1 to 2 mole equivalents, calculated on the compound I of formula III. The reaction is generally carried out at a temperature within the range of from -40 to +20C. The reaction is generally carried out in a solvent or delineate that is aprotic and is inert under the reaction conditions, for example, an ether, a hydrocarbon or a halogenated hydra-carbon, for example, Dixon, Bunsen, chloroform ormethylene chloride. A mixture of two or more solvents may be used. Examples of halogenating systems are: chlorine in chloroform and, especially, chlorine in Bunsen and t-bottle hypochlorite in Bunsen. In the latter two cases, the temperature is preferably from 5 to 20C, and especially from 5 to 10C.
A compound of formula IIIa, IIIb, or Icky is prefer-ably produced by removing the protective group from a compound of formula Ivan Ivy or Ivy, respectively, o'er or SHEA I sR3 SHEA - C, SR3 N Scorn N
ROOT Sorb ROW S
(Ivy) (Ivy) I lull
- 9 - HOE 82/S 001 OR
SHEA - C
Oslo ROOT
(Ivy) in which R, R2, , R3 and A are defined as above, and R4 denotes a hydroxy protecting group.
Preferred groups R4 are those which are compatible with the synthesis of the compound of formula IV and which may be removed under reaction conditions in which the resulting compound III is stable. Compound III has been found to be stable in the presence of a proton source, for example, hydrogen chloride, aqueous hydrochloric acid or aqueous hydrofluoric acid. Accordingly, one type of preferred hydroxy protecting groups R4 are those which may be removed under acidic conditions. Such groups are well known in the art and are for example, tetrahydropyranyl and tetrahydrofuranyl groups; acutely and petal groups, for example, of formula o'er ~R5 in which R6 and Rut which may be the same or different, each represents a hydrogen atom or a lower alkyd group, preferably a methyl group, or R6 and R7 together with the carbon atom to which they are attached represent a cycloalkyl ring having from 4 to 7 carbon atoms, for example, a tetrahydropyranyl or tetrahydrofuranyl ring;
and R5 represents a lower alkyd group, preferably a methyl or ethyl group.
SHEA - C
Oslo ROOT
(Ivy) in which R, R2, , R3 and A are defined as above, and R4 denotes a hydroxy protecting group.
Preferred groups R4 are those which are compatible with the synthesis of the compound of formula IV and which may be removed under reaction conditions in which the resulting compound III is stable. Compound III has been found to be stable in the presence of a proton source, for example, hydrogen chloride, aqueous hydrochloric acid or aqueous hydrofluoric acid. Accordingly, one type of preferred hydroxy protecting groups R4 are those which may be removed under acidic conditions. Such groups are well known in the art and are for example, tetrahydropyranyl and tetrahydrofuranyl groups; acutely and petal groups, for example, of formula o'er ~R5 in which R6 and Rut which may be the same or different, each represents a hydrogen atom or a lower alkyd group, preferably a methyl group, or R6 and R7 together with the carbon atom to which they are attached represent a cycloalkyl ring having from 4 to 7 carbon atoms, for example, a tetrahydropyranyl or tetrahydrofuranyl ring;
and R5 represents a lower alkyd group, preferably a methyl or ethyl group.
- 10 - HOE 82/S 001 R4 may also represent a sill group, for example, as described above in relation to R, for example, -SiR8R9R10 groups, in which R8, R9 and Rl0, which may be the same or different, each represents a lower alkyd group or an aureole group, for example, triethylsilyl, t-butyldimethyl-sill and methyldiphenylsilyl groups; and Stanley groups, for example, as described above in relation to R, for example, Sir R R groups, in which R , R and R
which may be the same or different, each represents a lower alkyd group, for example, a tri-n-butylstannyl group.
Preferred I groups are tetrahydropyranyl, 2-metho~yprop-yule and t-butyldimethylsilyl groups.
A t-butyldimethylsilyl group may be removed in a known manner by acid hydrolysis, for example, using moderately concentrated hydrochloric acid, for example EM
Hal, e.g., in tetrahydrofuran (of Belgian Patent Specie ligation No. 881 o'er hydrogen chloride in twitter-hydrofuran, dimethylformamide, Dixon, a lower alkanol, or acetonitrile; Tetra(n-butyl)ammonium fluoride in an acidic medium, e.g., in acetic acid (of Belgian Patent Specification No. 882 764); or aqueous hydrogen fluoride e.g., in the presence of acetonitrile (of J. Chum. Sock Perking 1, 1981, 2055). (The term 'known' is used herein to mean in actual use in the art or described in the literal lure of the art).
A compound of the general formula IV may be prepared according to the following reaction scheme:
o'er o'er OH - C Octal 9 SO
H
O I
VI I I
OR ~,~
I
ROOT
1;
I I 2 pi SR3 SHEA C, sR3 Scorn I
ROOT Sorb ROOT ROOT
Ivy Ivy Ivy in which R, Ray Rub, R3, R4 and A are as defined above.
A compound of formula VOW may be prepared as described in Belgian Patent Specification No. 882 764.
A compound of formula VOW may be converted into a compound of formula VI by reaction with a compound of formula VIII
R3 - S - R14 (VIII) in which R3 is as defined above and R14 represents a hydrogen atom or an alkali metal atom, especially a sodium or potassium atom. R3 preferably represents a straight chain lower alkyd group, especially an ethyl group, or a straight chain lower alkenyl group, especially an ally group.
The reaction is generally carried out in a solvent, preferably a erotic solvent, for example, water or an alcohol, or an aprotic, water-miscible solvent which is preferably polar, for example, dimethylformamide, dim ethyl sulphoxide, tetrahydrofuran or dioxin. The reaction temperature is, for example, from -20 to ~50, preferably from -10 to +20C.
To obtain a compound of formula V a compound of formula VI may be reacted, in the presence of a base, with a compound of formula IX
y1CH2C2R (IX) in which R is as defined above and ye represents a group that is capable of being replaced by a nucleophilic group and is, for example, a halogen atom, preferably a bromide or iodine atom, or a modified hydroxy group, preferably a sulphonyloxy group of the formula SYRIA in which R16 represents a lower alkyd or -CF3 group, or a phenol group which is us-substituted or is substituted by a nutria, Brigham or p-methyl group.
I Lo Y preferably represents a bromide or iodine atom or a methylsulphonate, trifluoromethylsulphonate~ toll-sulphonate or benzenesulphonate group.
The base may be inorganic, organic or organometallic, for example an alkali metal or alkaline earth metal hydroxide, oxide, carbonate, bicarbonate or hydride,for example, sodium hydroxide, magnesium oxide, potassium carbonate, potassium bicarbonate or sodium hydrides a tertiary amine, for example, a trialkylamine, for example, triethylamine, DABCO (diazabicyclo[2,2,2]octane), pardon, or an alkyl-substituted or amino-substituted or dialkylamino-substituted pardon, for example, NUN-dimethylaminopyridine, or colliding; a guanidine, for example, tetramethylguanidine; DUN (diazabicyclo[4,3,0]non-15 ennui) or DUB (diazabicyclo[5,4,0]undec-7-ene~, a polymeric base i.e., a base attached to an inert polymeric support e.g., Hunks base (diisopropylethylamine attached to e.g., polystyrene); a mutilated amine, for example, a mutilated alkyd- or arylamine, for example, lithium diisopropylamide (LEA), lithium hexamethyldisilazide, lithium piperidide, lithium 2,2,6,6-tetramethylpiperidide, or a Grignard reagent, for example, methyl magnesium bromide. Preferred bases are, for example, potassium carbonate, sodium hydrides lithium diisopropylamide and triethylamine.
The reaction is generally carried out in an aprotic solvent or delineate, for example, a tertiary aside, for example, dimethylformamide, dimethylacetamide or hexamethyl-phosphoramide; a hydrocarbon, for example, Bunsen or lot-gene; or an ether, for example, deathly ether, tetrahydro-Furman or Dixon; or acetonitrile, dim ethyl sulphoxide, or sulpholane. Dimethylformamide and dimethylacetamide are preferred. A mixture of two or more solvents and/or delineates may be used.
The reaction may be carried out at a temperature generally within the range of from -80C to +30C
preferably from -40 to +30C, and especially from -20 to ~2~C.
I
Jo ., I
From 1 to 1.5 moles of compound It are preferably used per mole of compound VI especially from 1 to 1.1 moles of IX per mole of VI. The base is used in an amount, for example, from 1 to 4 moles of base per mole of compound VI.
The reaction is preferably carried out by dissolving compound VI in a solvent, advantageously in dimethylform-aside with stirring, adding the base, adding the compound of formula IX and reacting at the desired temperature. The resulting compound of formula V may be worked up and is-fated in the usual manner, for example, using cremate-graphic and/or crystallization techniques, or the subset quint reaction may be carried out directly on the resulting reaction mixture after removal of any solvent that is not compatible with the subsequent reaction.
If R in formula V represents a carboxyl esterifying group, this group may be converted into another ester-lying group R, for example, to introduce a group R that is more easily removable under desired conditions. This transesterification is generally carried out as follows:
the ester for formula V is hydrolyzed in a known manner using, for example, acid or alkaline hydrolysis, prefer-ably using an alkali metal hydroxide, especially sodium or potassium hydroxide. The ester of formula V, for example, a methyl ester, is preferably hydrolyzed using an alkali metal hydroxide, especially one mole thereof per mole of the ester of formula V in a solvent, for example ethanol, methanol or water, or an aqueous-organic solvent, for example, tetrahydrofuran/water, ethanol/
water, or acetonitrile/water.
The reaction mixture may then be acidified to give a solution of pi 1 to 5, preferably 2 to I, and the free acid may then be isolated and, if desired, the free acid is then esterified with an esterifying agent capable of introducing a different esterifying group R, for example with an alcohol ROW in the presence of an acid or another . . , ~21~
activating agent, for example, dicyclohexylcarbodiimide, or with an alkylating agent RYE in which ye is as defined above. Preferably a salt may be isolated and esterified directly.
A compound of formula V may be converted into a compound of formula IV by treatment with a base in the presence of carbon disulphide followed by reaction with an assaulting agent, or by treatment with a base, then with carbon disulphide, and finally reaction with an assaulting agent. An assaulting agent is generally an activated carboxylic acid.
The activated carboxylic acid may be any activated acid derivative comprising the group R2. Such derivatives are well known in the art, and include acid halides, acid androids, and activated esters. An android may be symmetrical or asymmetrical. SCORN
For the introduction of a group a to give a compound of formula Ivan the assaulting Sorb agent preferably has one of the formulae Pa to Xb R2COZ (Pa) RbCOZ ( Xb) O O O O
Ray C - O - C - Rare _ C - O - C - Rub (Xc) (Ed) O O
q ,- " q Rub - C - O - C - I;
(X e) in which Ray and Rub are as defined above, and Z represents a halogen atom, especially a chlorine or bromide atom or represents an activated ester or aside, or a radical derived from an acid aside. Such coupling reagents are well known in the art of peptize chemistry.
I
In the case of formula Ivy/ the group S
I
S
may be introduced by means of an assaulting agent of formula XI o Hal - C - Hal in which Hal represents a halogen atom especially a chlorine atom.
For the introduction of a group to give a S
Jo to compound of formula Ivy, a dicarboxylic acid derivative of formula XII is used Casey A
CASEY
in which A and Z are as defined above, and Z preferably represents a halogen atom, especially z chlorine atom. As mentioned above, A represents the residue of a dicarboxylic acid or represents a direct bond. A is derived, for example, from Masonic, dimethylmalonic, succinic, glutaric, adipic, pimelic or phthalic acid.
The compound of formula V is preferably reacted first with a base, then with carbon disulphide, and then finally with the assaulting agent.
The base preferably has a pi 20, and is preferably a mutilated amine. Examples of preferred bases are lithium diisopropylamide, lithium 2,2,6,6-tetramethyl-piperidide, lithium cyclohexyl isopropylamide, lithium hexamethyl dieselized, and sodamide.
The reaction is generally carried out in an inert solvent, for example, an oxygenated hydrocarbon, preferably an ether, for example, deathly ether, tetrahydrofuran, , .
~211~1~8 Dixon, glum or diglyme. The reaction temperature is, for example, from -120 to +30C, preferably from -100 to -20C.
The amount of base used is for example, from 1 to 4 moles, calculated per mole of compound V, preferably from 2.0 to 3.0 moles of base. Carbon disulphide is preferably used in amount of from 1 to 5 moles, especially from 2 to 3 moles, per mole of compound V.
The reaction is preferably carried out as follows:
to a stirred solution of compound V under an inert atmosphere is added the base then carbon disulphide~ if desired in solution in the same solvent as compound V or in a different solvent, and finally the assaulting agent to complete the reaction.
There may then be admixed a erotic source having a pi less than 10, and especially from 5 to pharaoh example, acetic, citric, oxalic or formic acid.
The compound of the general formula I has R stereo chemistry at position 5. This is the stereochemistry found in naturally occurring penicillins and is, in general, preferable to US stereochemistry, more OR compounds being antibiotically active than are US compounds.
We have found a process that gives predominantly the desired OR compound of formula I. It has been proposed previously (British Patent Application AYE) to halogen ate a compound of formula IV i.e., a compound having a protected hydroxy group in the side chain attached to the 3-position, but we have found that this process gives only a OR halogenated compound, which in its turn, gives a compound analogous to that of formula I but having the undesired US stereochemistry. We have found that, very surprisingly, if the protective group is removed from compound IV prior to halogenation, the resulting halogenated compound of formula II is predominantly US. The isomer ratio 4S:4R in compound II resulting from the halogenation varies according to the reaction conditions but is, for example, in the range of from 3:1 to as high as 9:1. More-over, the OR and US isomers of formula II can be separated easily, for example, by chromatography.
The US halogenated intermediates of formula II give virtually exclusively a compound of formula I with the OR
stereochemistry as shown. The presumed participation of the free hydroxyl group of the side chain of formula II in giving the more starkly hindered compound of formula I
is also unexpected and constitutes a valuable advance in the preparation Go the penes compounds of formula I.
The compound of formula I is itself a very useful starting material for the preparation of various don-natives substituted at position 3, especially by -SR3, wherein R represents alkyd having 1-10 carbon atoms or substituted alkyd; particularly alkyd having 1-4 C-atoms, i.e., in the synthesis of 3-substituted 7-oxo-4-thia-1-azabicyclo[3,2,0]hept-2-ene 2-carboxylate derivatives, that possess antibacterial properties and which are useful for the treatment of bacterial infections in humans and animals.
The following Examples illustrate the invention. In them, temperatures are given in degrees Celsius.
....
I
Example 1 4-(R)-Allylthio-3lS)-[11(R)-~dimethyl-~2-methylproopal -silyloxy~ eth~l]azetidin-2-one To a stirred solution of 1.14 ml ox ally mercaptan and 0.4 g of sodium hydroxide in 25 ml of water under an argon atmosphere was added a solution of 2.87 g of 4-Aztecs'-- dimethyl-~2-methylprop yule silyloxy~ ethyl]azetid-in-2-one in 10 ml of methanol.
After 30 minutes, the mixture was partitioned between dichloromethane and water. The separated organic layer was washed with water, was dried over magnesium sulfite, evaporated to dryness and then chromatographed on silica gel. Elusion with ethyl acetate / hexane mixtures afforded 1.8 g of the title compound as white crystals.
)cDcl3 3420, 1767 cm (CDCl3) 0.05 ohs 0.88 (OH, s) 1.20 (OH, d, J6Hz) 2.9 - 3.2 (OH, m) 3.9 - 4.3 (OH, m, H-1') 3.84 (OH, d Jo 4 2Hz, H-4) 4.95 - 6.3 (OH, m) 7.28 (OH, broad s) Example 2 Methyl 2-(4(R)-allylthio-3-(S)-[1'(R)- methyl 2-methylprop-2-yl~ silyloxy~ ethyl]azetidin-2-on-1-yl) acetate To a stirred solution of 1.76 g of 4(R)-allylthio-3-(S~-[1'(R)- dim ethyl ~2-methylprop-2-yl~ silyloxy~
ethyl]azetidin-2-one in 60 ml of dry dimethylformamide was added 3.52 g of finely ground potassium carbonate and 0.6 ml of methyl bromoacetate. After 18 hours, the mixture was filtered and then partitioned between ethyl acetate and water. The separated organic layer was washed with I Lo water and dried over magnesium sulfite. Evaporation in vacua afforded a crude product which was cremate-graphed on silica gel. Elusion with ethyl acetate/hexane mixtures afforded 1.56 g of the title compound as a pale yellow oil.
CDCl3 1753, 1768 cm 1 (CDC13) 0006 (OH, s) 0.86 (OH, s) 1.23 (OH, d 6J.5Hz) 3.2 (OH, Al) 3.70 (OH, s) 3.6 - 4.3 (OH, m) 4.87 (lo, d J 2Hz, Ho 4.9 - 6.3 (OH, m) Example 3 4-Nitrobenzyl 2-(4(R)-allylthio-3(S)-[1'-(R) dimethYl 2-meth~lprop~2-yl~silyloxy~ ethyl]azetidin-~-on-1-yl)acetate To a stirred solution of 3.04 g of potassium hydroxide in 80 ml of 95 % ethanol was added a solution of 16 g of methyl2-(4(R)-allylthio-3tS)-[1'(R)-dimethyl~2-methvlprfop-2-yl~silyloxy~ethyl]azetidin-2-on-1-yl)acetate. After 10 minutes, the mixture was evaporated to about 1/5 of its original volume; 2 ml of dim ethyl acetamide were added, followed by a solution of 3.25 g of 4-nitrobenzyl bromide in 50 ml of dimethylacetamide. After 1 hour, the mixture assay partitioned between 0.01M Hal and ethyl acetate. The separated organic layers were washed with 0.01M Hal, with water, with cold, saturated sodium bit carbonate, and with brine, and were then dried and evaporated. The resulting crude product was cremate-graphed over silica gel; elusion with ethyl acetate/
hexane mixtures afford 19.5 g of the title compound as an oil.
I
- 21 - HOE 82/S 001 _ Max (CDC13) 1755, 1769 cm 1 ~(CDC13) 0.07 and 0~09 (OH, two singlets) 0.88 (OH, s) 1.25 (OH, d J6Hz) 3.2 (OH, m) 3.7 - 4.5 (OH, m) 4.95 (OH, d J2Hz, H-4 4.9 - 6.3 (OH, m) I - 8.35 (OH, m) Example 4 4-Nitrobenzyl 3, 3-di(acetylthlo)-[(3S,4R)-4-allylthlo 3~[1'(R) dimethyl-~2-methylprop-2-yl~ silyloxy~ ethyl]
2-azetidinon-1-yl)propenoate A solution of lithium hexamethyldisilazide was pro pared by the addition of n-butyllithium in hexane (2. 79 ml of a 1.6 M solution) to 0. 982 ml of hexamethyldisilazane in 8 ml of dry tetrahydrofuran at -10C, while stirring under argon. The solution was cooled to -78C and added by Connally to a solution of 0.98 g of 4-nitrobenzyl 2-(4(R)-allylthio-3(S)-[1'(R)-dimethyl-~2-methylproopal silyloxy~ ethyl]azetidin-2-on-1-yl) acetate in 8 ml of dry tetrahydrofuran at -78C, with stirring under argon.
After 5 minutes, 0.357 ml of carbon disulphide was added by syringe, followed by 0.748 ml of acetic android. The mixture was allowed to warm to room temperature, and 30 ml of dichloromethane was added, followed by 30 ml of water.
The organic layer was separated, and the aqueous layer was extracted with further dichloromethane. The combined organic extracts were washed with lo Hal, with water, and with a 12 % sodium chloride solution, and were then dried over magnesium sulfite and evaporated to give 1.38 g of an orange oil. 1.21 g of this crude product was chromatographed on silica gel using ethyl acetate/hexane mixtures as fluent to give 0.800 g of the title compound in purified form.
(cDcl3) 1778, 1745 cm 1 ~(CDCl3) 0.06 (OH, s) 0.85 (OH, s) 1.26 (OH, d J6Hz~
2.25 (OH, s) 2.35 (OH, 5) 3.11 - 3.52 (OH, m, 3-H) OWE (OH, d, J 6Hz) 4.14 4.39 (IT, m) 4.95 - 6.30 (OH, m) 5.35 (OH, s) 5.56 (IT, d J3Hz, 4-H) 7.44 - 8.38 (OH, m) Example pa 4-Nitrobenzyl 3,3-di(acetylthio)-2-[(3S,4R)-4-allylthio-3-~1'(R)-hydroxyethyl~-2-azetidinon-1-yl]propenoatlo To a solution of 0.601 g of 4-nitrobenzyl Dow-(acetylthio~-2-[(3S,4R)-4~allylthio-3-(1'(R)-dimeethyl-2-methylprop-2-yl~silyloxy~ethyl)-2 azetidinon-1-yl]-preappoint in 12 ml tetrahydrofuran was added a solution of 1 ml of concentrated hydrochloric acid and 1 ml of tetrahydrofuran. The solution was set aside for 24 hours and then evaporated in vacua. Bunsen was added and the mixture was evaporated to remove residual water to give 0.424 g of crude title product. A portion (0.197 g) of this crude material was chromatographed on silica gel eluding with ethyl acetate - hexane mixtures to give 0.142 g of pure title compound.
Max 1774, 1738 cm 1 (CDCl3) 1.26 (OH, d, J6Hz) ? 24 (OH, s) 2.38 (OH, so 3.35 (OH, d, J7Hz) 3.22 - 3.48 (OH, m) 3.98 - 4.45 (OH, m) ,. . .
I so ,...
.
5.30 (OH, s) 4.95 - 6.1 (OH, m) 7.42 - 8.23 (OH, m) Example 5b 4-Nitrobenzyl 3,3-di~acetylthio)-2 [issuer thio-3-~1'(R)-hydroxyethyl~-2-azetidlnon-1 yl1propenoate To a stirred solution of 0.088 g of 4-nitrobenzyl 3,3-di-(acetylthio)-2-[(3S,4R) 4-allylthio-3-(1'(R)-dimethyl-~2-methylprop-2-yl~silyloxy3ethyl~ 2-azetidinon-1-yl]propenoate in 5 ml of acetonitrile was added 2.35 ml of concentrated (40 %) hydrofluoric acid. A further volume of acetonitrile (5 ml) was added after 5 minutes, and the solution was quenched with a saturated aqueous sodium bicarbonate solution. The resulting solution was extracted with dichloromethane. The resulting organic phase was washed with water, with sodium bicarbonate, and then with brine. It was then dried over McCoy and chromatographed on silica gel, eluding with ethyl acetate -hexane mixtures to give 0.03 g of recovered starting material and then 0.0296 g of the title compound.
For spectral details see Example pa.
Example_5c 4-Nitrobenzyl 3,3-di(acetylthio)-2-[(3S,4R)-4-allylthio-3-1'(R)-hydroxyethyl~-2-azetidinon-1-yll]
preappoint To a solution of 5.58 g of 4-nitrobenzyl Dow-(acetylthio)-2-[(3S, 4R)-4-allylthio-3-(1'(R~-dimethyl-~2-methylprop-2-yl~silyloxy~ethyl~ 2-azetidinon-1-yl]-preappoint in 6.5 ml of tetrahydrofuran was added a freshly prepared solution of 3.72 g of hydrogen chloride in 32 ml of tetrahydrofuran.
The solution was set aside at room temperature until the reaction was complete, and was then evaporated in vacua. Chromatography on silica gel, eluding with ethyl acetate -hexane mixtures gave 3.10 g of the title compound.
For spectral details see Example pa.
I
Example pa 4-Nitrobenzyl 3,3-di(acetylthio)-2-[(3S,4S)-4-chloro 3-~1'(R)-~ydroxyeth~l~-2-azetidinon-1-yl]pro~enoatlo To a solution of 0.246 g of 4-nitrobenzyl Dow-(acetylthio)-2-[(3S,4R)-4~allylthio-3-(1'(R)-hydrooxyethyl)-2-azetidinon-1-yl]propenoate in 13 ml of Bunsen was added under an inert atmosphere 0.095 ml of t-butylhypochlorite.
When the starting material had been consumed the reaction mixture was chromatographed on silica gel to give as the minor product 0.045 g of 4-nitrobenzyl Dow-(acetyl-thio)-2-[(3S,4R)-4-chloro-3~ (R)-hydroxyethyl)-2-azetidinon-1-yl]propenoate (20 I) and as the major product 0.121 g of the title compound.
For spectral details see Example aye.
Example 6b 4-Nitrobenzyl 3,3-di(acetylthio)-2-[(3S,4S)-4-chloro-3-~1'(R)-hydroxyethy~ -2-azetidinon-1-Yl]propenoate To a solution of 3.10 g of 4-nitrobenzyl Dow-(acetylthio)-2-[(3S,4R)-4-allylthio-3-(1'(R)-hydrooxyethyl)-2-azetidinon-1-yl]propenoate in 70 ml of dry Bunsen cooled to 6 was added drops a solution of 1.5 mow equivalent of chlorine in 9.5 ml of carbon tetrachloride.
When the starting material had been consumed, the solution was reduced in volume in vacua and chromatographed on silica gel, eluding with ethyl acetate - hexane mixtures to give as the minor product 0.695 g of 4-nitrobenzyl 3,3-di-(acetylthio)-2-[(3S,4R)-4-chloro-3-(1(R)-hyydroxy-ethyl)-2-azetidinon-1-yl]propenoate, and as the major product 1.808 g of the title compound.
For spectral details see Example aye.
Example 7 4-Nitrobenzyl (5R,6S) 6-~8'(R)-h~droxyethyl~-7-oxo-4-thia-3-thioxo-1-azabicyclo[3,2,o]hept-2-ane 2-carboxylate To a solution of 0.525 g of 4-nitrobenzyl Dow-35(acetylthio)-2-[~3S,4S)-4-chloro-3-(1'(R)-hydroxyeethyl)-I, 2-azetidinon-1-yl]propenoate in 15 ml of dioxin and 1.5 ml of water was added OWE g of imidazole. When the react lion was complete the solution was diluted with ethyl acetate and water, acidified with dilute hydrochloric acid and extracted. The aqueous phase was extracted with a second volume of ethyl acetate. The combined ethyl acetate solution was washed with water and then with brine, dried over McCoy and evaporated in vacua to give the title compound as an orange solid in quantitative yield.
Max (liquid film) 1791, 1751 cm 1 (CDCl3) 1.39 (OH, d, J6Hz) 3.00 (OH, s) C H
3.76 (OH, Ed, JOB c~c~ 4Hz~ Joy 4.05 - 4.53 (OH, m) 5.35 (OH, s) 5.45 us 5.95 (OH, d, 5-H) 7.36 - 8.45 (OH, m).
Example 8 3(S)-~1'(R)-Dimethyl(2-methylprop-2-yl)silyloxyethHoyle (R)-ethylthioazetidin-2-one To a stirred solution of 2.03 g of sodium hydroxide in 70 ml of water at 0C under an argon atmosphere was added 3.94 g of ethanol they'll. After 30 minutes stirring, a solution of 12.6 g of 3(S~-{1'(R)-dimethyl(2-methylprop-2-yl)silyloxy-ethyl~-4-acetoxyazetidin-2-one in 200 ml of methanol was added. The mixture was warmed to room temperature and, after 90 minutes, was partitioned between ethyl acetate and water. The aqueous layer was further washed with ethyl acetate. The combined organic layers were back-washed with brine, dried over sodium sulfite, and evaporated to dryness. 6.9 g of the title product were obtained. Yield: 54 %
'I
I
Max lCDCl3) 1765 cm J (CDCl3) 0.10 ohs 0 90 (OH, s) 1026 (OH, d, J = 6 Ho) 1.33 (OH, t, J = 7 Ho 2.68 12H, q, J = 7Hz) 3.16 (OH, m) 4.1 - 4.3 (OH, m) 4.85 (OH, d, J = 2 Ho) 6.78 (OH, broad s).
Example 9 Methyl 2-[3(S)-~ (R)-~dimeth~l(2-methylprop-2-yl)s lye-_ oxyethyl}~4(R)-ethylthio-azetidin-2-on-1-yl]acetatlo To a stirred solution of 6.9 g of Dow-methyl(2-methylprop-2-yl)silyloxyethyl3-4(R)-ethyllthio -azetidin-2-one in 150 ml of dry dimethylformamide was added 13.15 g of finely ground an hydrous potassium carbonate and 2.82 ml of methyl bromoacetate. After 24 hours, the mixture was filtered and then partitioned between ethyl acetate and water. The aqueous layer was adjusted to pi 2 by drops addition of dilute hydrochloric acid, and then back-extracted with ethyl acetate. The combined organic layers were washed with water, dried over sodium sulfite, and evaporated n vacua to give an orange oil, which was chromatographed over silica gel.
Elusion with ethyl acetate/hexane mixtures afforded 6.37 g of the title compound as a pale yellow oil.
Yield: 72 %.
Max (CDCl3) 1749 jester) and 1760 (B-lactam) cm (CDCl3) 0.06 (OH, s) 0.36 (OH, s) 1.3 (OH, m) 2.58 (OH, q) J = 6Hz) 3.12 OH dud, J = 2Hz and 4 Ho) 3.70 (OH, s) 3.93 (OH, dud, J gem = 17 Ho) 4.3 (lo, my 4.92 (OH, d, J = 2Hz)~
I
Example 10 4-Nitrobenzyl 2-[3-(S)-~1~(R)-dimethyl-(2-methylprop-2-yl)-silyloxyethyl3-4(R)-e~ylthio-azetidin-2-on-1yule]-acetate To a solution of 6 .37 g of methyl 2-[3(S)-1'(R)-dimethyl(2-methylprop-2-yl)silyloxyethyl~-4(R)-ethhealth-azetidin-2-on-1-yl]acetate in 25 ml of 95 % ethanol was added a solution of 1.16 g of potassium hydroxide in 25 ml of 95 ethanol. After 15 minutes, the mixture was evaporated in vacua to dryness. The product was dissolved immediately in Z5 ml of dimethylacetamide, and 4.24 g of solid 4-nitrobenzyl bromide were added with vigorous stirring. After 60 minutes, the mixture was partitioned between ethyl acetate and water. The separated aqueous layer was washed with further ethyl acetate; the combined organic layers were backwashes with water, then with brine, and were then dried over sodium sulfite and evaporated in vacua to afford an orange oil. Cremate-graph over silica gel, eluding with ethyl acetate/hexane mixtures afforded the title compound as a pale yellow, viscous oil. Yield: 6.18 g, 80 %.
Max (CDCl3) 1765 (B-lactam) and 1755 (ester)cm 1 (CDC13) 0.05 (OH, s) 0.08 (OH, s) 0.88 (OH, s) 1.25 (OH, t, J = 7Hz) 1.28 13H, d, J = 6 Ho) 2.58 (OH, q, J = 7Hz) 3.18 I dud, J = 2 Ho and 4 Ho) 4.05 (OH, dud, Gem = 18 Ho) 4.1 - 4.3 (OH, m) 4.93 (OH, d, J = 2Hz) , ~29~L18 - 28 - HOE 82lS 001 Example 11 4-Nitrobenzyl 3,3-di(acetylthio)-2 [(3S,4R) 4-ethylthio-3-(1l(R)-(dimethyl-~2-meth~lprop-2-yl~siilyloxy~
ethyl)-2-azetidinon-1-yl]propenoate A solution of 2.0 g of 4-nitrobenzyl 2-[3S,4R)-4-ethylthio-3-l1'(R)-~dimethyl-2 -methylprop-2-yl~ silylox~ -ethyl)-2-azetidinon-1-yl]acetate in 30 ml of dry twitter-hydrofuran was held under an inert atmosphere and cooled to -78. To the well-stirred solution was added a cooled (-78C) preformed solution of lithium hexamethyldisilazide (prepared by addition of bottle lithium (1.55 molar, 6.01 ml, 9.31 Molly) to a tetrahydrofuran solution (20 ml) of hexamethyldisilazane (2.05 ml) cooled to -10). After 5 minutes, 0.747 ml of carbon disulphide was added, followed after a further 5 minutes stirring by 1.56 ml of acetic android, and the solution was warmed to -20.
80 ml of ethyl acetate was added to the solution, followed by 150 ml of dilute hydrochloric acid (0.4 molar). The aqueous layer was extracted with a further volume of ethyl acetate. The combined ethyl acetate phase was washed with brine, then dried over magnesium sulfite and evaporated in vacua to yield 3.03 g of the title -compound, which was used subsequently without further purification.
Max (CDCl3) 1776, 1739, 1715 cm 1 d (CDC13) 0.06 (OH, s) 0.85 (OH, s) 1.06 - 1.64 OH m) 2.10 - 3.16 (OH, m) 2.23 (OH, s) 2.35 (OH, s) 3.25 - 3.50 (OH, m, 3-H) 4.05 - 4.67 (OH, m) 5.34 (OH, s) 5.56 (OH, Ahab 7.37 - 3.44 (OH, m).
IT
'I
I
Example 12 4-Nitrobenzyl 3,3-di(acetylthi_ -2-[(3S,4R)-4-ethylthio-3~ (R)-h~droxyethyl,3-2-azetidinon-1~y~
preappoint 0.303 g of 4-nitrobenzyl 3,3-di(acetylthio)-2-[(3S,4R)-4-ethylthio-3-(1'(R)-~dimethyl-~2-methylpprop-2-yl~-silylox~ ethyl)~2-azetidinon 1-yl]propenoate was dissolved in a solution of 12 mow equivalent of hydrogen chloride in S ml of tetrahydrofuran. The solution was stirred for 6 hours then evaporated in vacua to 1/3 of its volume. Ethanol free chloroform was added and the solution evaporated. The residue was chromatographed on silica gel eluding with ethyl acetate - hexane mixtures to give 0.066 g of recovered starting material and 0.12g of the title compound.
(Max) 1770, 1738 cm 1 (CDCl3) 1.03 - 1.63 (OH, m) 2.00 - 3 18 (OH, m) 3.19 - 3.48 (OH, m, 3-H) 3.95 - 4.46 (OH, m) 5.30 (OH, s) 5. 3 OH 4~.,3B' 7.33 - 8.37 (OH, m).
Example aye 4-Nitrobenzyl 3,3-di(acetylthio)-2-[(3S,4S)-4-chloro-3-~1'(R)-h~droxyethyl~-2-azetidinon-1-yl]prrepent A solution of 0.10 g of 4-nitrobenzyl dustily-thio)-2-[(3S,4R)-4-ethylthio-3-~11(R)-hydroxyethyllo azetidinon-1-yl]propenoate in 1.3 ml of ethanol-free chloroform was cooled to -60 under an inert atmosphere.
To this solution was added a solution of chlorine in carbon tetrachloride until the starting material had been consumed. The reaction was evaporated in awoke and chromatographed on silica gel to give 0.032 g of the title compound.
or I, ~21~L~8 Max (liquid film) 1790, 1739 cm 1 d (CDC13) 1.37 (OH, d, J7Hz) 2.24 (OH, s) 2.39 (OH, s) 3.58 (OH, Ed, JOB, O-CH-CH3 10Hz, JOB
5 Ho, 3-H) 4.00 - 4.56 (OH, m) 5~30 (OH, s) 6.27 (OH, I, 4-H) 7.38 - 8.25 (OH, m).
Example lob _Nitrobenzyl 3,3-di~acetylthio)-2-~3S,4S) 4-chloro-3-~1'(R)-hvdroxyethyl-2-azetidinon~1-yl]proopenoate To a solution of 0.10 g of 4-nitrobenzyl Dow-15 (acetylthio)-2-[(3S,4R) 4-ethylthio-3-~1'(R)-hydroxyethyl-2-azetidinon-1-yl]propenoate in 2 ml of dry Bunsen cooled to 6 was added slowly a solution of 1.5 mole equivalent of chlorine in carbon tetrachloride until the starting material had been consumed. The solution was then chromatographed on silica gel, eluding with ethyl acetate -hexane mixtures to give as a minor product 0.011 g of 4-nitrobenzyl 3,3-di(acetylthio)-2-[(3S,4R) sheller-3-(1'(R)-hydroxyethyl)-2-azetidinon-1-yl]propenoatlo, thetas the major product, 0.065 g of the title compound.
For spectral details see Example aye.
Example 14 4-Nitrobenzyl 3,3-di(ace~y~_hio)-2-[(3S,4R)-4-chloro-3-(1'(R)-dimethyl-~2-methylprop-2-yl~silyllucks ethyl)-2-azetidinon-1-yl]propenoate A stirred solution of 3.S19 g of 4-nitrobenzyl-3,3-di(acetylthio)-2-[(3S,4R)-4-allylthio-3-(1'1R)Dow-methyl methylprop-2-yl}silyloxy~ethyl)-2-azetidinon-1-yl]-propenoate in 20 ml of ethanol-free chloroform was cooled to -60. To it was added a solution of 0.48 g of chlorine in 5.6 ml of carbon tetrachloride. The resulting solution was maintained at -60 for 20 minutes, _, I
Lo and was then warmed to room temperature, evaporated in vacua and chromatographed on silica gel to yield 2.32 g of the title compound. my 145--146 (from ethyl acetate/
hexane) Max (CDCl3) 1795, 1743 cm 1 (CDCl3) 0.06 (OH, s) 0.85 (OH, s) 1.31 (OH, d, J6Hz) 2.25 (OH, s) 2.40 (OH, s) 3.53 (OH, Ed, J3B,4~ 2Hz~ J3B/SiOCH
3Hz, 3-H) 4.08 - 4.50 (OH, m) 5.37 ohs 6.28 (OH, d, 4-H) 7.45 - 8.42 (OH, m) Example 15 4-Nitrobenzyl ! 5S,6S) 6-(~(R)-dimethyl-2-methyl-prop-2-yl}silyloxy~ethyl)-7-oxo-4-thia-3-thioxo-1--azabicyclor3,2,0]hept-2-ane-2-carboxylate To a stirred solution of 0.741 g of 4-nitrobenzyl 3,3-di(acetylthio)-2-[(3S,4R)4-chloro-3-(1(R)-~dimmethyl-~2-methylprop-2-yl~ silyloxy3 ethyl-2-azetidinon-1-yl]-preappoint in 20 ml of dioxin and 2 ml of water was added 0.247 g of imidazole. After 20 minutes the solution was diluted with 120 ml of ethyl acetate and extracted with dilute hydrochloric acid, followed by brine. The organic phase was dried over McCoy and evaporated in vacua to give the title compound in quantitative yield.
Max (liquid film) 1793, 1755 cm 1 tCDC13) 0.11 (OH, s) 0.89 (OH, s) 1.41 (OH, d, J6Hz) 3.96 (OH, Ed, JOB Seiko OH 6B,5B
9Hz, 6-H) 4.13 - 4.63 (OH, m) 5.25 - 5.48 (OH, m) 5.36 (OH, s) 6.05 (lo, d, 5-H) 7 37 - 8.45 (OH, m) Example 16 4-Nitrobenzyl 5(R),3-ethylthio-6-(S)-~8(R)-hydroxy-ethyl oxo-4-thia-1-azabicyclo[3,2,0]hept-2-ene 2-carboxylate To a stirred solution of 0.1~ g of 4-nitrobenzyl (5R,6S)-~1'(R)-hydroxyethyl3-7-oxo-~-thia-3-thioxoo-1-azabicyclo [eighteen 2-carboxylate in 10 ml of dry twitter-hydrofuran was added 0.094 ml of ethyl disopropylamine followed by 0.119 ml of iodoethane. When the reaction was shown to be complete (by means of thin layer chrome-tography) the solvent was removed in vacua and the residue chromatographed on 10 g of silica gel (eluding with ethyl acetate-hexane) to give 0.14 g of the title compound.
Example 17 Potassium 5(R), 3-ethylthio-6(S)-~8(R)-hydroxyethyl-~
7-oxo-4-thia-1-azabicyclo[3,2,0]hept-2-ene 2-carboxylate To a solution of 0.139 g of 4-nitrobenzyl 5(R), 3-ethylthio-6(S~-~1(R)-hydroxyethyl~-7-oxo-~-thia ~-azabicyclo [eighteen 2-carboxylate 15 ml of ethyl acetate was added 15 ml of an aqueous solution of 0.034 g of potassium bicarbonate followed by 0.28 g of palladium on charcoal. The mixture was hydrogenated at 50 psi for one hour then filtered through '~YFI,O' which is a trade mark for a filtration aid. The aqueous phase was extracted once with 10 ml of fresh ethyl acetate and then hydra-lucid to give 0.06 g of the title compound.
lZl~ 8 Example 18 4-Nitrobenzyl 2-(4(R)~ethylthio-3(S)-[1'(R)-dimethyl [2-methylprop-2-yl]silyloxyethyl]-2-azetidinon-1-yyule-(4-oxo-1,3-dithietan -2-ylidene)acetate A solution of lithium hexamethyldisilazide was prepared by the addition of n-butyllithium in hexane (4.21 ml of a 1.6M solution) to 2.13 ml of hexamethyl-disilazane in 10 ml of dry tetrahydrofuran at 0C while stirring under nitrogen. The solution was added via a Connally to a solution of 1.08 g of 4-nitrobenzyl 2-~4(R)-ethylthio-3(S)-[1'(R)-dimethyl-~2-methylprRipley silyloxyethyl]-2-azetidinon-1-yl)acetate in 10 ml of dry tetrahydrofuran at -78C, with stirring under nitrogen.
After 5 minutes, 0.35 ml of carbon disulphide was added by syringe and after a further 90 minutes phosgene in Tulane (3.56 ml of a 12.5 % solution) was added by syringe. The mixture was stirred for 90 minutes and poured into 50 ml of deathly ether and 10 ml of EM acetic acid. The organic layer was separated, washed with water, 12 sodium chloride solution, dried over magnesium sulfite and evaporated to give an orange oil. Chromatography over silica gel using deathly ether/
hexane mixtures as fluent gave 0.485 g of the title compound in purified form.
of ax (CDC13) 1770, 1760 cm 6(CDCl3) 0.04 (OH, s) 0.81 (OH, s) 1.18 (OH, t, J = 7 Ho) 1.22 (OH, d, J = 7 Ho) 2.51 (OH, q, J = 7 Ho) 3.18 (OH, dud, J = 2.7 and 3.7 Ho) 4.24 (OH, do, J = 2.7 and 7 Ho) 5.31 (OH, d, J = 2.7 Ho) 5.23, 5.45 (OH, ABE J = 13 Ho) 7.55, 8.23 (OH, AHAB, J = 9 Ho) . . .
I
Example 19 4-Nitrobenzyl-2-(4(R)-ethyl-thio-3(S)-[1'(R)-hydroox-ethyl]-2-azetidinon-1-yl)-2-(4-oxo-1,3~dithietan-22-ylidene) acetate 0.30 g of 4-Nitrobenzyl 2-(4(R)-ethylthio-3(S)-[1(R)-dimethyl~2-methylprop-2-yl}silyloxyethyl]-2--azetidinon-1-yl)-2-(4-oxo-1,3-dithietan-2-ylidene)) acetate was dissolved in 4 ml of dry DMF containing a trace of -queenly under a nitrogen atmosphere protected from light. The solution was treated with 5 mow equivalent of hydrogen chloride in 2.2 ml of DMF. The solution was stirred for 4 hours and diluted with 5 ml of water, poured into 20 ml of deathly ether and the organic layer separated. The aqueous portion was no-extracted with a further volume of deathly ether and the organic fractions combined washed with water, dried over magnesium sulfite and evaporated to give a yellow oil. Chromatography over silica gel using deathly ether/
hexane mixtures as eluant gave 0.21 g of the title compound in purified form.
Max (CDC13) 34 50, 1785, 1760 cm 1, o (CDCl3; 1.13 OH t, J = 7 Ho 1.18 (OH, d, J = 7 Ho) 2.39 (OH, by s) 2.51 (OH, q, J = 7 Ho) 3.17 (OH, dud, J = 2.7 and 3.3 Ho) 4.22 (OH, m) 5.24 (OH, d, J = 2.7 Ho) 5.29 (OH, s) 7.52, 8.17 (OH, AHAB, J = 9 Ho) Example 20 4-Nitrobenzyl 2-(4(S)-chloro-3(S)-[1'(R)-hydroxyethyl]-2-azetidinon-1~ 2-(4-oxo-1,3-dithietan-2-ylidene)_ acetate X
~2~118 A solution of 0.208 g of 4-nitrobenzyl 2-(4~R)-ethylthio-3(S~-[1'(R)-hydroxyethyl]-2-azetidinon-1yule-(4-oxo-1,3-dithietan-2-ylidene)acetate in 1 ml of ethanol-free chloroform was cooled to -30C under a nitrogen atmosphere and treated with 1.1 mow equivalent of chlorine in 0.82 ml of carbon tetrachloride. The reaction mixture was permitted to warm to room tempera-lure and the solvent evaporated in vacua. Chromatography on silica gel using deathly ether/hexane mixtures as 10 eluant gave 0.015 g of 4-nitrobenzyl 2-(4(R)-chloro-3(S)-[1(R)-hydxoxyethyl]-2-azetidinon-1-yl-2-(4-oxo-1,33-dithietan-2-ylidene)acetate and 0.03 g of the title compound.
Mecca (CDCL3) 1775 cm 1.
(CDC13) 1.45 (OH, d, J = 6.3 Ho) 3.59 (OH, dud, J = 4.4 and 9.3 Ho) 4.37 (OH, m) 5.33, 5.40 (OH, ABE J = 13 I
6.08 t1H, d, J = 4.4 Ho) 7.53 , 8.27 I AHAB, J = 8.6 Ho) Example 21 4-Nitrobenzyl (OR, US) 6-(8(R)-hydroxyethyl)-7=
oxo-~-thia-3-thioxo-1-azabicyclo[3,2,0]hept-2-ane--2-carboxylate To a solution of 0.028 g 4-nitrobenzyl 2-(4(S)-chloro-3(S)-[1'(R)-hydroxyethyl]-2-azetidinon-1-yll-2-30 (4-oxo-1,3-dithietan-2-ylidene)acetate in 1 ml of 10 %
aqueous Dixon at 5C was added a trace of imidazole.
When the reaction was complete the solution was diluted with deathly ether and water, acidified with dilute hydrochloric acid and extracted. The aqueous phase was extracted with a second volume of deathly ether and the organic portions combined, washed with water, 12 %
r Jo sodium chloride solution, dried over magnesium sulfite and evaporated to give 0.01 g of crude product. Comparison of its NOR spectrum with that of the product of example 7 proved the existence of the title compound in the product mixture.
which may be the same or different, each represents a lower alkyd group, for example, a tri-n-butylstannyl group.
Preferred I groups are tetrahydropyranyl, 2-metho~yprop-yule and t-butyldimethylsilyl groups.
A t-butyldimethylsilyl group may be removed in a known manner by acid hydrolysis, for example, using moderately concentrated hydrochloric acid, for example EM
Hal, e.g., in tetrahydrofuran (of Belgian Patent Specie ligation No. 881 o'er hydrogen chloride in twitter-hydrofuran, dimethylformamide, Dixon, a lower alkanol, or acetonitrile; Tetra(n-butyl)ammonium fluoride in an acidic medium, e.g., in acetic acid (of Belgian Patent Specification No. 882 764); or aqueous hydrogen fluoride e.g., in the presence of acetonitrile (of J. Chum. Sock Perking 1, 1981, 2055). (The term 'known' is used herein to mean in actual use in the art or described in the literal lure of the art).
A compound of the general formula IV may be prepared according to the following reaction scheme:
o'er o'er OH - C Octal 9 SO
H
O I
VI I I
OR ~,~
I
ROOT
1;
I I 2 pi SR3 SHEA C, sR3 Scorn I
ROOT Sorb ROOT ROOT
Ivy Ivy Ivy in which R, Ray Rub, R3, R4 and A are as defined above.
A compound of formula VOW may be prepared as described in Belgian Patent Specification No. 882 764.
A compound of formula VOW may be converted into a compound of formula VI by reaction with a compound of formula VIII
R3 - S - R14 (VIII) in which R3 is as defined above and R14 represents a hydrogen atom or an alkali metal atom, especially a sodium or potassium atom. R3 preferably represents a straight chain lower alkyd group, especially an ethyl group, or a straight chain lower alkenyl group, especially an ally group.
The reaction is generally carried out in a solvent, preferably a erotic solvent, for example, water or an alcohol, or an aprotic, water-miscible solvent which is preferably polar, for example, dimethylformamide, dim ethyl sulphoxide, tetrahydrofuran or dioxin. The reaction temperature is, for example, from -20 to ~50, preferably from -10 to +20C.
To obtain a compound of formula V a compound of formula VI may be reacted, in the presence of a base, with a compound of formula IX
y1CH2C2R (IX) in which R is as defined above and ye represents a group that is capable of being replaced by a nucleophilic group and is, for example, a halogen atom, preferably a bromide or iodine atom, or a modified hydroxy group, preferably a sulphonyloxy group of the formula SYRIA in which R16 represents a lower alkyd or -CF3 group, or a phenol group which is us-substituted or is substituted by a nutria, Brigham or p-methyl group.
I Lo Y preferably represents a bromide or iodine atom or a methylsulphonate, trifluoromethylsulphonate~ toll-sulphonate or benzenesulphonate group.
The base may be inorganic, organic or organometallic, for example an alkali metal or alkaline earth metal hydroxide, oxide, carbonate, bicarbonate or hydride,for example, sodium hydroxide, magnesium oxide, potassium carbonate, potassium bicarbonate or sodium hydrides a tertiary amine, for example, a trialkylamine, for example, triethylamine, DABCO (diazabicyclo[2,2,2]octane), pardon, or an alkyl-substituted or amino-substituted or dialkylamino-substituted pardon, for example, NUN-dimethylaminopyridine, or colliding; a guanidine, for example, tetramethylguanidine; DUN (diazabicyclo[4,3,0]non-15 ennui) or DUB (diazabicyclo[5,4,0]undec-7-ene~, a polymeric base i.e., a base attached to an inert polymeric support e.g., Hunks base (diisopropylethylamine attached to e.g., polystyrene); a mutilated amine, for example, a mutilated alkyd- or arylamine, for example, lithium diisopropylamide (LEA), lithium hexamethyldisilazide, lithium piperidide, lithium 2,2,6,6-tetramethylpiperidide, or a Grignard reagent, for example, methyl magnesium bromide. Preferred bases are, for example, potassium carbonate, sodium hydrides lithium diisopropylamide and triethylamine.
The reaction is generally carried out in an aprotic solvent or delineate, for example, a tertiary aside, for example, dimethylformamide, dimethylacetamide or hexamethyl-phosphoramide; a hydrocarbon, for example, Bunsen or lot-gene; or an ether, for example, deathly ether, tetrahydro-Furman or Dixon; or acetonitrile, dim ethyl sulphoxide, or sulpholane. Dimethylformamide and dimethylacetamide are preferred. A mixture of two or more solvents and/or delineates may be used.
The reaction may be carried out at a temperature generally within the range of from -80C to +30C
preferably from -40 to +30C, and especially from -20 to ~2~C.
I
Jo ., I
From 1 to 1.5 moles of compound It are preferably used per mole of compound VI especially from 1 to 1.1 moles of IX per mole of VI. The base is used in an amount, for example, from 1 to 4 moles of base per mole of compound VI.
The reaction is preferably carried out by dissolving compound VI in a solvent, advantageously in dimethylform-aside with stirring, adding the base, adding the compound of formula IX and reacting at the desired temperature. The resulting compound of formula V may be worked up and is-fated in the usual manner, for example, using cremate-graphic and/or crystallization techniques, or the subset quint reaction may be carried out directly on the resulting reaction mixture after removal of any solvent that is not compatible with the subsequent reaction.
If R in formula V represents a carboxyl esterifying group, this group may be converted into another ester-lying group R, for example, to introduce a group R that is more easily removable under desired conditions. This transesterification is generally carried out as follows:
the ester for formula V is hydrolyzed in a known manner using, for example, acid or alkaline hydrolysis, prefer-ably using an alkali metal hydroxide, especially sodium or potassium hydroxide. The ester of formula V, for example, a methyl ester, is preferably hydrolyzed using an alkali metal hydroxide, especially one mole thereof per mole of the ester of formula V in a solvent, for example ethanol, methanol or water, or an aqueous-organic solvent, for example, tetrahydrofuran/water, ethanol/
water, or acetonitrile/water.
The reaction mixture may then be acidified to give a solution of pi 1 to 5, preferably 2 to I, and the free acid may then be isolated and, if desired, the free acid is then esterified with an esterifying agent capable of introducing a different esterifying group R, for example with an alcohol ROW in the presence of an acid or another . . , ~21~
activating agent, for example, dicyclohexylcarbodiimide, or with an alkylating agent RYE in which ye is as defined above. Preferably a salt may be isolated and esterified directly.
A compound of formula V may be converted into a compound of formula IV by treatment with a base in the presence of carbon disulphide followed by reaction with an assaulting agent, or by treatment with a base, then with carbon disulphide, and finally reaction with an assaulting agent. An assaulting agent is generally an activated carboxylic acid.
The activated carboxylic acid may be any activated acid derivative comprising the group R2. Such derivatives are well known in the art, and include acid halides, acid androids, and activated esters. An android may be symmetrical or asymmetrical. SCORN
For the introduction of a group a to give a compound of formula Ivan the assaulting Sorb agent preferably has one of the formulae Pa to Xb R2COZ (Pa) RbCOZ ( Xb) O O O O
Ray C - O - C - Rare _ C - O - C - Rub (Xc) (Ed) O O
q ,- " q Rub - C - O - C - I;
(X e) in which Ray and Rub are as defined above, and Z represents a halogen atom, especially a chlorine or bromide atom or represents an activated ester or aside, or a radical derived from an acid aside. Such coupling reagents are well known in the art of peptize chemistry.
I
In the case of formula Ivy/ the group S
I
S
may be introduced by means of an assaulting agent of formula XI o Hal - C - Hal in which Hal represents a halogen atom especially a chlorine atom.
For the introduction of a group to give a S
Jo to compound of formula Ivy, a dicarboxylic acid derivative of formula XII is used Casey A
CASEY
in which A and Z are as defined above, and Z preferably represents a halogen atom, especially z chlorine atom. As mentioned above, A represents the residue of a dicarboxylic acid or represents a direct bond. A is derived, for example, from Masonic, dimethylmalonic, succinic, glutaric, adipic, pimelic or phthalic acid.
The compound of formula V is preferably reacted first with a base, then with carbon disulphide, and then finally with the assaulting agent.
The base preferably has a pi 20, and is preferably a mutilated amine. Examples of preferred bases are lithium diisopropylamide, lithium 2,2,6,6-tetramethyl-piperidide, lithium cyclohexyl isopropylamide, lithium hexamethyl dieselized, and sodamide.
The reaction is generally carried out in an inert solvent, for example, an oxygenated hydrocarbon, preferably an ether, for example, deathly ether, tetrahydrofuran, , .
~211~1~8 Dixon, glum or diglyme. The reaction temperature is, for example, from -120 to +30C, preferably from -100 to -20C.
The amount of base used is for example, from 1 to 4 moles, calculated per mole of compound V, preferably from 2.0 to 3.0 moles of base. Carbon disulphide is preferably used in amount of from 1 to 5 moles, especially from 2 to 3 moles, per mole of compound V.
The reaction is preferably carried out as follows:
to a stirred solution of compound V under an inert atmosphere is added the base then carbon disulphide~ if desired in solution in the same solvent as compound V or in a different solvent, and finally the assaulting agent to complete the reaction.
There may then be admixed a erotic source having a pi less than 10, and especially from 5 to pharaoh example, acetic, citric, oxalic or formic acid.
The compound of the general formula I has R stereo chemistry at position 5. This is the stereochemistry found in naturally occurring penicillins and is, in general, preferable to US stereochemistry, more OR compounds being antibiotically active than are US compounds.
We have found a process that gives predominantly the desired OR compound of formula I. It has been proposed previously (British Patent Application AYE) to halogen ate a compound of formula IV i.e., a compound having a protected hydroxy group in the side chain attached to the 3-position, but we have found that this process gives only a OR halogenated compound, which in its turn, gives a compound analogous to that of formula I but having the undesired US stereochemistry. We have found that, very surprisingly, if the protective group is removed from compound IV prior to halogenation, the resulting halogenated compound of formula II is predominantly US. The isomer ratio 4S:4R in compound II resulting from the halogenation varies according to the reaction conditions but is, for example, in the range of from 3:1 to as high as 9:1. More-over, the OR and US isomers of formula II can be separated easily, for example, by chromatography.
The US halogenated intermediates of formula II give virtually exclusively a compound of formula I with the OR
stereochemistry as shown. The presumed participation of the free hydroxyl group of the side chain of formula II in giving the more starkly hindered compound of formula I
is also unexpected and constitutes a valuable advance in the preparation Go the penes compounds of formula I.
The compound of formula I is itself a very useful starting material for the preparation of various don-natives substituted at position 3, especially by -SR3, wherein R represents alkyd having 1-10 carbon atoms or substituted alkyd; particularly alkyd having 1-4 C-atoms, i.e., in the synthesis of 3-substituted 7-oxo-4-thia-1-azabicyclo[3,2,0]hept-2-ene 2-carboxylate derivatives, that possess antibacterial properties and which are useful for the treatment of bacterial infections in humans and animals.
The following Examples illustrate the invention. In them, temperatures are given in degrees Celsius.
....
I
Example 1 4-(R)-Allylthio-3lS)-[11(R)-~dimethyl-~2-methylproopal -silyloxy~ eth~l]azetidin-2-one To a stirred solution of 1.14 ml ox ally mercaptan and 0.4 g of sodium hydroxide in 25 ml of water under an argon atmosphere was added a solution of 2.87 g of 4-Aztecs'-- dimethyl-~2-methylprop yule silyloxy~ ethyl]azetid-in-2-one in 10 ml of methanol.
After 30 minutes, the mixture was partitioned between dichloromethane and water. The separated organic layer was washed with water, was dried over magnesium sulfite, evaporated to dryness and then chromatographed on silica gel. Elusion with ethyl acetate / hexane mixtures afforded 1.8 g of the title compound as white crystals.
)cDcl3 3420, 1767 cm (CDCl3) 0.05 ohs 0.88 (OH, s) 1.20 (OH, d, J6Hz) 2.9 - 3.2 (OH, m) 3.9 - 4.3 (OH, m, H-1') 3.84 (OH, d Jo 4 2Hz, H-4) 4.95 - 6.3 (OH, m) 7.28 (OH, broad s) Example 2 Methyl 2-(4(R)-allylthio-3-(S)-[1'(R)- methyl 2-methylprop-2-yl~ silyloxy~ ethyl]azetidin-2-on-1-yl) acetate To a stirred solution of 1.76 g of 4(R)-allylthio-3-(S~-[1'(R)- dim ethyl ~2-methylprop-2-yl~ silyloxy~
ethyl]azetidin-2-one in 60 ml of dry dimethylformamide was added 3.52 g of finely ground potassium carbonate and 0.6 ml of methyl bromoacetate. After 18 hours, the mixture was filtered and then partitioned between ethyl acetate and water. The separated organic layer was washed with I Lo water and dried over magnesium sulfite. Evaporation in vacua afforded a crude product which was cremate-graphed on silica gel. Elusion with ethyl acetate/hexane mixtures afforded 1.56 g of the title compound as a pale yellow oil.
CDCl3 1753, 1768 cm 1 (CDC13) 0006 (OH, s) 0.86 (OH, s) 1.23 (OH, d 6J.5Hz) 3.2 (OH, Al) 3.70 (OH, s) 3.6 - 4.3 (OH, m) 4.87 (lo, d J 2Hz, Ho 4.9 - 6.3 (OH, m) Example 3 4-Nitrobenzyl 2-(4(R)-allylthio-3(S)-[1'-(R) dimethYl 2-meth~lprop~2-yl~silyloxy~ ethyl]azetidin-~-on-1-yl)acetate To a stirred solution of 3.04 g of potassium hydroxide in 80 ml of 95 % ethanol was added a solution of 16 g of methyl2-(4(R)-allylthio-3tS)-[1'(R)-dimethyl~2-methvlprfop-2-yl~silyloxy~ethyl]azetidin-2-on-1-yl)acetate. After 10 minutes, the mixture was evaporated to about 1/5 of its original volume; 2 ml of dim ethyl acetamide were added, followed by a solution of 3.25 g of 4-nitrobenzyl bromide in 50 ml of dimethylacetamide. After 1 hour, the mixture assay partitioned between 0.01M Hal and ethyl acetate. The separated organic layers were washed with 0.01M Hal, with water, with cold, saturated sodium bit carbonate, and with brine, and were then dried and evaporated. The resulting crude product was cremate-graphed over silica gel; elusion with ethyl acetate/
hexane mixtures afford 19.5 g of the title compound as an oil.
I
- 21 - HOE 82/S 001 _ Max (CDC13) 1755, 1769 cm 1 ~(CDC13) 0.07 and 0~09 (OH, two singlets) 0.88 (OH, s) 1.25 (OH, d J6Hz) 3.2 (OH, m) 3.7 - 4.5 (OH, m) 4.95 (OH, d J2Hz, H-4 4.9 - 6.3 (OH, m) I - 8.35 (OH, m) Example 4 4-Nitrobenzyl 3, 3-di(acetylthlo)-[(3S,4R)-4-allylthlo 3~[1'(R) dimethyl-~2-methylprop-2-yl~ silyloxy~ ethyl]
2-azetidinon-1-yl)propenoate A solution of lithium hexamethyldisilazide was pro pared by the addition of n-butyllithium in hexane (2. 79 ml of a 1.6 M solution) to 0. 982 ml of hexamethyldisilazane in 8 ml of dry tetrahydrofuran at -10C, while stirring under argon. The solution was cooled to -78C and added by Connally to a solution of 0.98 g of 4-nitrobenzyl 2-(4(R)-allylthio-3(S)-[1'(R)-dimethyl-~2-methylproopal silyloxy~ ethyl]azetidin-2-on-1-yl) acetate in 8 ml of dry tetrahydrofuran at -78C, with stirring under argon.
After 5 minutes, 0.357 ml of carbon disulphide was added by syringe, followed by 0.748 ml of acetic android. The mixture was allowed to warm to room temperature, and 30 ml of dichloromethane was added, followed by 30 ml of water.
The organic layer was separated, and the aqueous layer was extracted with further dichloromethane. The combined organic extracts were washed with lo Hal, with water, and with a 12 % sodium chloride solution, and were then dried over magnesium sulfite and evaporated to give 1.38 g of an orange oil. 1.21 g of this crude product was chromatographed on silica gel using ethyl acetate/hexane mixtures as fluent to give 0.800 g of the title compound in purified form.
(cDcl3) 1778, 1745 cm 1 ~(CDCl3) 0.06 (OH, s) 0.85 (OH, s) 1.26 (OH, d J6Hz~
2.25 (OH, s) 2.35 (OH, 5) 3.11 - 3.52 (OH, m, 3-H) OWE (OH, d, J 6Hz) 4.14 4.39 (IT, m) 4.95 - 6.30 (OH, m) 5.35 (OH, s) 5.56 (IT, d J3Hz, 4-H) 7.44 - 8.38 (OH, m) Example pa 4-Nitrobenzyl 3,3-di(acetylthio)-2-[(3S,4R)-4-allylthio-3-~1'(R)-hydroxyethyl~-2-azetidinon-1-yl]propenoatlo To a solution of 0.601 g of 4-nitrobenzyl Dow-(acetylthio~-2-[(3S,4R)-4~allylthio-3-(1'(R)-dimeethyl-2-methylprop-2-yl~silyloxy~ethyl)-2 azetidinon-1-yl]-preappoint in 12 ml tetrahydrofuran was added a solution of 1 ml of concentrated hydrochloric acid and 1 ml of tetrahydrofuran. The solution was set aside for 24 hours and then evaporated in vacua. Bunsen was added and the mixture was evaporated to remove residual water to give 0.424 g of crude title product. A portion (0.197 g) of this crude material was chromatographed on silica gel eluding with ethyl acetate - hexane mixtures to give 0.142 g of pure title compound.
Max 1774, 1738 cm 1 (CDCl3) 1.26 (OH, d, J6Hz) ? 24 (OH, s) 2.38 (OH, so 3.35 (OH, d, J7Hz) 3.22 - 3.48 (OH, m) 3.98 - 4.45 (OH, m) ,. . .
I so ,...
.
5.30 (OH, s) 4.95 - 6.1 (OH, m) 7.42 - 8.23 (OH, m) Example 5b 4-Nitrobenzyl 3,3-di~acetylthio)-2 [issuer thio-3-~1'(R)-hydroxyethyl~-2-azetidlnon-1 yl1propenoate To a stirred solution of 0.088 g of 4-nitrobenzyl 3,3-di-(acetylthio)-2-[(3S,4R) 4-allylthio-3-(1'(R)-dimethyl-~2-methylprop-2-yl~silyloxy3ethyl~ 2-azetidinon-1-yl]propenoate in 5 ml of acetonitrile was added 2.35 ml of concentrated (40 %) hydrofluoric acid. A further volume of acetonitrile (5 ml) was added after 5 minutes, and the solution was quenched with a saturated aqueous sodium bicarbonate solution. The resulting solution was extracted with dichloromethane. The resulting organic phase was washed with water, with sodium bicarbonate, and then with brine. It was then dried over McCoy and chromatographed on silica gel, eluding with ethyl acetate -hexane mixtures to give 0.03 g of recovered starting material and then 0.0296 g of the title compound.
For spectral details see Example pa.
Example_5c 4-Nitrobenzyl 3,3-di(acetylthio)-2-[(3S,4R)-4-allylthio-3-1'(R)-hydroxyethyl~-2-azetidinon-1-yll]
preappoint To a solution of 5.58 g of 4-nitrobenzyl Dow-(acetylthio)-2-[(3S, 4R)-4-allylthio-3-(1'(R~-dimethyl-~2-methylprop-2-yl~silyloxy~ethyl~ 2-azetidinon-1-yl]-preappoint in 6.5 ml of tetrahydrofuran was added a freshly prepared solution of 3.72 g of hydrogen chloride in 32 ml of tetrahydrofuran.
The solution was set aside at room temperature until the reaction was complete, and was then evaporated in vacua. Chromatography on silica gel, eluding with ethyl acetate -hexane mixtures gave 3.10 g of the title compound.
For spectral details see Example pa.
I
Example pa 4-Nitrobenzyl 3,3-di(acetylthio)-2-[(3S,4S)-4-chloro 3-~1'(R)-~ydroxyeth~l~-2-azetidinon-1-yl]pro~enoatlo To a solution of 0.246 g of 4-nitrobenzyl Dow-(acetylthio)-2-[(3S,4R)-4~allylthio-3-(1'(R)-hydrooxyethyl)-2-azetidinon-1-yl]propenoate in 13 ml of Bunsen was added under an inert atmosphere 0.095 ml of t-butylhypochlorite.
When the starting material had been consumed the reaction mixture was chromatographed on silica gel to give as the minor product 0.045 g of 4-nitrobenzyl Dow-(acetyl-thio)-2-[(3S,4R)-4-chloro-3~ (R)-hydroxyethyl)-2-azetidinon-1-yl]propenoate (20 I) and as the major product 0.121 g of the title compound.
For spectral details see Example aye.
Example 6b 4-Nitrobenzyl 3,3-di(acetylthio)-2-[(3S,4S)-4-chloro-3-~1'(R)-hydroxyethy~ -2-azetidinon-1-Yl]propenoate To a solution of 3.10 g of 4-nitrobenzyl Dow-(acetylthio)-2-[(3S,4R)-4-allylthio-3-(1'(R)-hydrooxyethyl)-2-azetidinon-1-yl]propenoate in 70 ml of dry Bunsen cooled to 6 was added drops a solution of 1.5 mow equivalent of chlorine in 9.5 ml of carbon tetrachloride.
When the starting material had been consumed, the solution was reduced in volume in vacua and chromatographed on silica gel, eluding with ethyl acetate - hexane mixtures to give as the minor product 0.695 g of 4-nitrobenzyl 3,3-di-(acetylthio)-2-[(3S,4R)-4-chloro-3-(1(R)-hyydroxy-ethyl)-2-azetidinon-1-yl]propenoate, and as the major product 1.808 g of the title compound.
For spectral details see Example aye.
Example 7 4-Nitrobenzyl (5R,6S) 6-~8'(R)-h~droxyethyl~-7-oxo-4-thia-3-thioxo-1-azabicyclo[3,2,o]hept-2-ane 2-carboxylate To a solution of 0.525 g of 4-nitrobenzyl Dow-35(acetylthio)-2-[~3S,4S)-4-chloro-3-(1'(R)-hydroxyeethyl)-I, 2-azetidinon-1-yl]propenoate in 15 ml of dioxin and 1.5 ml of water was added OWE g of imidazole. When the react lion was complete the solution was diluted with ethyl acetate and water, acidified with dilute hydrochloric acid and extracted. The aqueous phase was extracted with a second volume of ethyl acetate. The combined ethyl acetate solution was washed with water and then with brine, dried over McCoy and evaporated in vacua to give the title compound as an orange solid in quantitative yield.
Max (liquid film) 1791, 1751 cm 1 (CDCl3) 1.39 (OH, d, J6Hz) 3.00 (OH, s) C H
3.76 (OH, Ed, JOB c~c~ 4Hz~ Joy 4.05 - 4.53 (OH, m) 5.35 (OH, s) 5.45 us 5.95 (OH, d, 5-H) 7.36 - 8.45 (OH, m).
Example 8 3(S)-~1'(R)-Dimethyl(2-methylprop-2-yl)silyloxyethHoyle (R)-ethylthioazetidin-2-one To a stirred solution of 2.03 g of sodium hydroxide in 70 ml of water at 0C under an argon atmosphere was added 3.94 g of ethanol they'll. After 30 minutes stirring, a solution of 12.6 g of 3(S~-{1'(R)-dimethyl(2-methylprop-2-yl)silyloxy-ethyl~-4-acetoxyazetidin-2-one in 200 ml of methanol was added. The mixture was warmed to room temperature and, after 90 minutes, was partitioned between ethyl acetate and water. The aqueous layer was further washed with ethyl acetate. The combined organic layers were back-washed with brine, dried over sodium sulfite, and evaporated to dryness. 6.9 g of the title product were obtained. Yield: 54 %
'I
I
Max lCDCl3) 1765 cm J (CDCl3) 0.10 ohs 0 90 (OH, s) 1026 (OH, d, J = 6 Ho) 1.33 (OH, t, J = 7 Ho 2.68 12H, q, J = 7Hz) 3.16 (OH, m) 4.1 - 4.3 (OH, m) 4.85 (OH, d, J = 2 Ho) 6.78 (OH, broad s).
Example 9 Methyl 2-[3(S)-~ (R)-~dimeth~l(2-methylprop-2-yl)s lye-_ oxyethyl}~4(R)-ethylthio-azetidin-2-on-1-yl]acetatlo To a stirred solution of 6.9 g of Dow-methyl(2-methylprop-2-yl)silyloxyethyl3-4(R)-ethyllthio -azetidin-2-one in 150 ml of dry dimethylformamide was added 13.15 g of finely ground an hydrous potassium carbonate and 2.82 ml of methyl bromoacetate. After 24 hours, the mixture was filtered and then partitioned between ethyl acetate and water. The aqueous layer was adjusted to pi 2 by drops addition of dilute hydrochloric acid, and then back-extracted with ethyl acetate. The combined organic layers were washed with water, dried over sodium sulfite, and evaporated n vacua to give an orange oil, which was chromatographed over silica gel.
Elusion with ethyl acetate/hexane mixtures afforded 6.37 g of the title compound as a pale yellow oil.
Yield: 72 %.
Max (CDCl3) 1749 jester) and 1760 (B-lactam) cm (CDCl3) 0.06 (OH, s) 0.36 (OH, s) 1.3 (OH, m) 2.58 (OH, q) J = 6Hz) 3.12 OH dud, J = 2Hz and 4 Ho) 3.70 (OH, s) 3.93 (OH, dud, J gem = 17 Ho) 4.3 (lo, my 4.92 (OH, d, J = 2Hz)~
I
Example 10 4-Nitrobenzyl 2-[3-(S)-~1~(R)-dimethyl-(2-methylprop-2-yl)-silyloxyethyl3-4(R)-e~ylthio-azetidin-2-on-1yule]-acetate To a solution of 6 .37 g of methyl 2-[3(S)-1'(R)-dimethyl(2-methylprop-2-yl)silyloxyethyl~-4(R)-ethhealth-azetidin-2-on-1-yl]acetate in 25 ml of 95 % ethanol was added a solution of 1.16 g of potassium hydroxide in 25 ml of 95 ethanol. After 15 minutes, the mixture was evaporated in vacua to dryness. The product was dissolved immediately in Z5 ml of dimethylacetamide, and 4.24 g of solid 4-nitrobenzyl bromide were added with vigorous stirring. After 60 minutes, the mixture was partitioned between ethyl acetate and water. The separated aqueous layer was washed with further ethyl acetate; the combined organic layers were backwashes with water, then with brine, and were then dried over sodium sulfite and evaporated in vacua to afford an orange oil. Cremate-graph over silica gel, eluding with ethyl acetate/hexane mixtures afforded the title compound as a pale yellow, viscous oil. Yield: 6.18 g, 80 %.
Max (CDCl3) 1765 (B-lactam) and 1755 (ester)cm 1 (CDC13) 0.05 (OH, s) 0.08 (OH, s) 0.88 (OH, s) 1.25 (OH, t, J = 7Hz) 1.28 13H, d, J = 6 Ho) 2.58 (OH, q, J = 7Hz) 3.18 I dud, J = 2 Ho and 4 Ho) 4.05 (OH, dud, Gem = 18 Ho) 4.1 - 4.3 (OH, m) 4.93 (OH, d, J = 2Hz) , ~29~L18 - 28 - HOE 82lS 001 Example 11 4-Nitrobenzyl 3,3-di(acetylthio)-2 [(3S,4R) 4-ethylthio-3-(1l(R)-(dimethyl-~2-meth~lprop-2-yl~siilyloxy~
ethyl)-2-azetidinon-1-yl]propenoate A solution of 2.0 g of 4-nitrobenzyl 2-[3S,4R)-4-ethylthio-3-l1'(R)-~dimethyl-2 -methylprop-2-yl~ silylox~ -ethyl)-2-azetidinon-1-yl]acetate in 30 ml of dry twitter-hydrofuran was held under an inert atmosphere and cooled to -78. To the well-stirred solution was added a cooled (-78C) preformed solution of lithium hexamethyldisilazide (prepared by addition of bottle lithium (1.55 molar, 6.01 ml, 9.31 Molly) to a tetrahydrofuran solution (20 ml) of hexamethyldisilazane (2.05 ml) cooled to -10). After 5 minutes, 0.747 ml of carbon disulphide was added, followed after a further 5 minutes stirring by 1.56 ml of acetic android, and the solution was warmed to -20.
80 ml of ethyl acetate was added to the solution, followed by 150 ml of dilute hydrochloric acid (0.4 molar). The aqueous layer was extracted with a further volume of ethyl acetate. The combined ethyl acetate phase was washed with brine, then dried over magnesium sulfite and evaporated in vacua to yield 3.03 g of the title -compound, which was used subsequently without further purification.
Max (CDCl3) 1776, 1739, 1715 cm 1 d (CDC13) 0.06 (OH, s) 0.85 (OH, s) 1.06 - 1.64 OH m) 2.10 - 3.16 (OH, m) 2.23 (OH, s) 2.35 (OH, s) 3.25 - 3.50 (OH, m, 3-H) 4.05 - 4.67 (OH, m) 5.34 (OH, s) 5.56 (OH, Ahab 7.37 - 3.44 (OH, m).
IT
'I
I
Example 12 4-Nitrobenzyl 3,3-di(acetylthi_ -2-[(3S,4R)-4-ethylthio-3~ (R)-h~droxyethyl,3-2-azetidinon-1~y~
preappoint 0.303 g of 4-nitrobenzyl 3,3-di(acetylthio)-2-[(3S,4R)-4-ethylthio-3-(1'(R)-~dimethyl-~2-methylpprop-2-yl~-silylox~ ethyl)~2-azetidinon 1-yl]propenoate was dissolved in a solution of 12 mow equivalent of hydrogen chloride in S ml of tetrahydrofuran. The solution was stirred for 6 hours then evaporated in vacua to 1/3 of its volume. Ethanol free chloroform was added and the solution evaporated. The residue was chromatographed on silica gel eluding with ethyl acetate - hexane mixtures to give 0.066 g of recovered starting material and 0.12g of the title compound.
(Max) 1770, 1738 cm 1 (CDCl3) 1.03 - 1.63 (OH, m) 2.00 - 3 18 (OH, m) 3.19 - 3.48 (OH, m, 3-H) 3.95 - 4.46 (OH, m) 5.30 (OH, s) 5. 3 OH 4~.,3B' 7.33 - 8.37 (OH, m).
Example aye 4-Nitrobenzyl 3,3-di(acetylthio)-2-[(3S,4S)-4-chloro-3-~1'(R)-h~droxyethyl~-2-azetidinon-1-yl]prrepent A solution of 0.10 g of 4-nitrobenzyl dustily-thio)-2-[(3S,4R)-4-ethylthio-3-~11(R)-hydroxyethyllo azetidinon-1-yl]propenoate in 1.3 ml of ethanol-free chloroform was cooled to -60 under an inert atmosphere.
To this solution was added a solution of chlorine in carbon tetrachloride until the starting material had been consumed. The reaction was evaporated in awoke and chromatographed on silica gel to give 0.032 g of the title compound.
or I, ~21~L~8 Max (liquid film) 1790, 1739 cm 1 d (CDC13) 1.37 (OH, d, J7Hz) 2.24 (OH, s) 2.39 (OH, s) 3.58 (OH, Ed, JOB, O-CH-CH3 10Hz, JOB
5 Ho, 3-H) 4.00 - 4.56 (OH, m) 5~30 (OH, s) 6.27 (OH, I, 4-H) 7.38 - 8.25 (OH, m).
Example lob _Nitrobenzyl 3,3-di~acetylthio)-2-~3S,4S) 4-chloro-3-~1'(R)-hvdroxyethyl-2-azetidinon~1-yl]proopenoate To a solution of 0.10 g of 4-nitrobenzyl Dow-15 (acetylthio)-2-[(3S,4R) 4-ethylthio-3-~1'(R)-hydroxyethyl-2-azetidinon-1-yl]propenoate in 2 ml of dry Bunsen cooled to 6 was added slowly a solution of 1.5 mole equivalent of chlorine in carbon tetrachloride until the starting material had been consumed. The solution was then chromatographed on silica gel, eluding with ethyl acetate -hexane mixtures to give as a minor product 0.011 g of 4-nitrobenzyl 3,3-di(acetylthio)-2-[(3S,4R) sheller-3-(1'(R)-hydroxyethyl)-2-azetidinon-1-yl]propenoatlo, thetas the major product, 0.065 g of the title compound.
For spectral details see Example aye.
Example 14 4-Nitrobenzyl 3,3-di(ace~y~_hio)-2-[(3S,4R)-4-chloro-3-(1'(R)-dimethyl-~2-methylprop-2-yl~silyllucks ethyl)-2-azetidinon-1-yl]propenoate A stirred solution of 3.S19 g of 4-nitrobenzyl-3,3-di(acetylthio)-2-[(3S,4R)-4-allylthio-3-(1'1R)Dow-methyl methylprop-2-yl}silyloxy~ethyl)-2-azetidinon-1-yl]-propenoate in 20 ml of ethanol-free chloroform was cooled to -60. To it was added a solution of 0.48 g of chlorine in 5.6 ml of carbon tetrachloride. The resulting solution was maintained at -60 for 20 minutes, _, I
Lo and was then warmed to room temperature, evaporated in vacua and chromatographed on silica gel to yield 2.32 g of the title compound. my 145--146 (from ethyl acetate/
hexane) Max (CDCl3) 1795, 1743 cm 1 (CDCl3) 0.06 (OH, s) 0.85 (OH, s) 1.31 (OH, d, J6Hz) 2.25 (OH, s) 2.40 (OH, s) 3.53 (OH, Ed, J3B,4~ 2Hz~ J3B/SiOCH
3Hz, 3-H) 4.08 - 4.50 (OH, m) 5.37 ohs 6.28 (OH, d, 4-H) 7.45 - 8.42 (OH, m) Example 15 4-Nitrobenzyl ! 5S,6S) 6-(~(R)-dimethyl-2-methyl-prop-2-yl}silyloxy~ethyl)-7-oxo-4-thia-3-thioxo-1--azabicyclor3,2,0]hept-2-ane-2-carboxylate To a stirred solution of 0.741 g of 4-nitrobenzyl 3,3-di(acetylthio)-2-[(3S,4R)4-chloro-3-(1(R)-~dimmethyl-~2-methylprop-2-yl~ silyloxy3 ethyl-2-azetidinon-1-yl]-preappoint in 20 ml of dioxin and 2 ml of water was added 0.247 g of imidazole. After 20 minutes the solution was diluted with 120 ml of ethyl acetate and extracted with dilute hydrochloric acid, followed by brine. The organic phase was dried over McCoy and evaporated in vacua to give the title compound in quantitative yield.
Max (liquid film) 1793, 1755 cm 1 tCDC13) 0.11 (OH, s) 0.89 (OH, s) 1.41 (OH, d, J6Hz) 3.96 (OH, Ed, JOB Seiko OH 6B,5B
9Hz, 6-H) 4.13 - 4.63 (OH, m) 5.25 - 5.48 (OH, m) 5.36 (OH, s) 6.05 (lo, d, 5-H) 7 37 - 8.45 (OH, m) Example 16 4-Nitrobenzyl 5(R),3-ethylthio-6-(S)-~8(R)-hydroxy-ethyl oxo-4-thia-1-azabicyclo[3,2,0]hept-2-ene 2-carboxylate To a stirred solution of 0.1~ g of 4-nitrobenzyl (5R,6S)-~1'(R)-hydroxyethyl3-7-oxo-~-thia-3-thioxoo-1-azabicyclo [eighteen 2-carboxylate in 10 ml of dry twitter-hydrofuran was added 0.094 ml of ethyl disopropylamine followed by 0.119 ml of iodoethane. When the reaction was shown to be complete (by means of thin layer chrome-tography) the solvent was removed in vacua and the residue chromatographed on 10 g of silica gel (eluding with ethyl acetate-hexane) to give 0.14 g of the title compound.
Example 17 Potassium 5(R), 3-ethylthio-6(S)-~8(R)-hydroxyethyl-~
7-oxo-4-thia-1-azabicyclo[3,2,0]hept-2-ene 2-carboxylate To a solution of 0.139 g of 4-nitrobenzyl 5(R), 3-ethylthio-6(S~-~1(R)-hydroxyethyl~-7-oxo-~-thia ~-azabicyclo [eighteen 2-carboxylate 15 ml of ethyl acetate was added 15 ml of an aqueous solution of 0.034 g of potassium bicarbonate followed by 0.28 g of palladium on charcoal. The mixture was hydrogenated at 50 psi for one hour then filtered through '~YFI,O' which is a trade mark for a filtration aid. The aqueous phase was extracted once with 10 ml of fresh ethyl acetate and then hydra-lucid to give 0.06 g of the title compound.
lZl~ 8 Example 18 4-Nitrobenzyl 2-(4(R)~ethylthio-3(S)-[1'(R)-dimethyl [2-methylprop-2-yl]silyloxyethyl]-2-azetidinon-1-yyule-(4-oxo-1,3-dithietan -2-ylidene)acetate A solution of lithium hexamethyldisilazide was prepared by the addition of n-butyllithium in hexane (4.21 ml of a 1.6M solution) to 2.13 ml of hexamethyl-disilazane in 10 ml of dry tetrahydrofuran at 0C while stirring under nitrogen. The solution was added via a Connally to a solution of 1.08 g of 4-nitrobenzyl 2-~4(R)-ethylthio-3(S)-[1'(R)-dimethyl-~2-methylprRipley silyloxyethyl]-2-azetidinon-1-yl)acetate in 10 ml of dry tetrahydrofuran at -78C, with stirring under nitrogen.
After 5 minutes, 0.35 ml of carbon disulphide was added by syringe and after a further 90 minutes phosgene in Tulane (3.56 ml of a 12.5 % solution) was added by syringe. The mixture was stirred for 90 minutes and poured into 50 ml of deathly ether and 10 ml of EM acetic acid. The organic layer was separated, washed with water, 12 sodium chloride solution, dried over magnesium sulfite and evaporated to give an orange oil. Chromatography over silica gel using deathly ether/
hexane mixtures as fluent gave 0.485 g of the title compound in purified form.
of ax (CDC13) 1770, 1760 cm 6(CDCl3) 0.04 (OH, s) 0.81 (OH, s) 1.18 (OH, t, J = 7 Ho) 1.22 (OH, d, J = 7 Ho) 2.51 (OH, q, J = 7 Ho) 3.18 (OH, dud, J = 2.7 and 3.7 Ho) 4.24 (OH, do, J = 2.7 and 7 Ho) 5.31 (OH, d, J = 2.7 Ho) 5.23, 5.45 (OH, ABE J = 13 Ho) 7.55, 8.23 (OH, AHAB, J = 9 Ho) . . .
I
Example 19 4-Nitrobenzyl-2-(4(R)-ethyl-thio-3(S)-[1'(R)-hydroox-ethyl]-2-azetidinon-1-yl)-2-(4-oxo-1,3~dithietan-22-ylidene) acetate 0.30 g of 4-Nitrobenzyl 2-(4(R)-ethylthio-3(S)-[1(R)-dimethyl~2-methylprop-2-yl}silyloxyethyl]-2--azetidinon-1-yl)-2-(4-oxo-1,3-dithietan-2-ylidene)) acetate was dissolved in 4 ml of dry DMF containing a trace of -queenly under a nitrogen atmosphere protected from light. The solution was treated with 5 mow equivalent of hydrogen chloride in 2.2 ml of DMF. The solution was stirred for 4 hours and diluted with 5 ml of water, poured into 20 ml of deathly ether and the organic layer separated. The aqueous portion was no-extracted with a further volume of deathly ether and the organic fractions combined washed with water, dried over magnesium sulfite and evaporated to give a yellow oil. Chromatography over silica gel using deathly ether/
hexane mixtures as eluant gave 0.21 g of the title compound in purified form.
Max (CDC13) 34 50, 1785, 1760 cm 1, o (CDCl3; 1.13 OH t, J = 7 Ho 1.18 (OH, d, J = 7 Ho) 2.39 (OH, by s) 2.51 (OH, q, J = 7 Ho) 3.17 (OH, dud, J = 2.7 and 3.3 Ho) 4.22 (OH, m) 5.24 (OH, d, J = 2.7 Ho) 5.29 (OH, s) 7.52, 8.17 (OH, AHAB, J = 9 Ho) Example 20 4-Nitrobenzyl 2-(4(S)-chloro-3(S)-[1'(R)-hydroxyethyl]-2-azetidinon-1~ 2-(4-oxo-1,3-dithietan-2-ylidene)_ acetate X
~2~118 A solution of 0.208 g of 4-nitrobenzyl 2-(4~R)-ethylthio-3(S~-[1'(R)-hydroxyethyl]-2-azetidinon-1yule-(4-oxo-1,3-dithietan-2-ylidene)acetate in 1 ml of ethanol-free chloroform was cooled to -30C under a nitrogen atmosphere and treated with 1.1 mow equivalent of chlorine in 0.82 ml of carbon tetrachloride. The reaction mixture was permitted to warm to room tempera-lure and the solvent evaporated in vacua. Chromatography on silica gel using deathly ether/hexane mixtures as 10 eluant gave 0.015 g of 4-nitrobenzyl 2-(4(R)-chloro-3(S)-[1(R)-hydxoxyethyl]-2-azetidinon-1-yl-2-(4-oxo-1,33-dithietan-2-ylidene)acetate and 0.03 g of the title compound.
Mecca (CDCL3) 1775 cm 1.
(CDC13) 1.45 (OH, d, J = 6.3 Ho) 3.59 (OH, dud, J = 4.4 and 9.3 Ho) 4.37 (OH, m) 5.33, 5.40 (OH, ABE J = 13 I
6.08 t1H, d, J = 4.4 Ho) 7.53 , 8.27 I AHAB, J = 8.6 Ho) Example 21 4-Nitrobenzyl (OR, US) 6-(8(R)-hydroxyethyl)-7=
oxo-~-thia-3-thioxo-1-azabicyclo[3,2,0]hept-2-ane--2-carboxylate To a solution of 0.028 g 4-nitrobenzyl 2-(4(S)-chloro-3(S)-[1'(R)-hydroxyethyl]-2-azetidinon-1-yll-2-30 (4-oxo-1,3-dithietan-2-ylidene)acetate in 1 ml of 10 %
aqueous Dixon at 5C was added a trace of imidazole.
When the reaction was complete the solution was diluted with deathly ether and water, acidified with dilute hydrochloric acid and extracted. The aqueous phase was extracted with a second volume of deathly ether and the organic portions combined, washed with water, 12 %
r Jo sodium chloride solution, dried over magnesium sulfite and evaporated to give 0.01 g of crude product. Comparison of its NOR spectrum with that of the product of example 7 proved the existence of the title compound in the product mixture.
Claims (3)
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for the preparation of a compound of the formula IIa, lIb or IIc IIa IIb IIc wherein R represents a carboxyl esterifying group removable by hydrolysis, photolysis, reduction or enzyme action to give the free acid, R1 represents a chlorine or bromine atom R2a and R2b, which may be the same or different, each represents an alkyl group having from 1 to 4 carbon atoms, an aryl group, and A represents a direct bond or the residue of a dicarboxylic acid, in which a compound of the general formula IIIa, IIIb or IIIc IIIa IIIb IIIc wherein R; R?,R? and A are as defined above, and R3 represents an alkyl group having from 1 to 8 carbon atoms, or an alkenyl group having up to 6 carbon atoms, is halogenated to give a compound of the formula IIa, IIb or IIc.
2. The process as claimed in claim 1, wherein R3 is an ethyl group or an allyl group.
3. A compound of the general formula IIa, IIb or IIc IIa IIb IIc wherein R represents a carboxyl esterifying group removable by hydrolysis, photolysis, reduction, or enzyme action to give the free acid R1 represents a chlorine or bromine atom, R? and R?, which may be the same or different, each represents an alkyl group having from 1 to 4 carbon atoms, an aryl group, and A represents a direct bond or the residue of a dicarboxylic acid, whenever obtained according to the process as claimed in claim 1 or claim 2 or by an obvious chemical equivalent thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000487761A CA1211118A (en) | 1982-03-26 | 1985-07-30 | 7-oxo-4-thia-1-azabicyclo[3,2,0]heptane derivatives |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8208983 | 1982-03-26 | ||
| GB8208983 | 1982-03-26 | ||
| CA000424484A CA1206148A (en) | 1982-03-26 | 1983-03-25 | 7-oxo-4-thia-1-azabicyclo¬3,2,0|heptane derivatives |
| CA000487761A CA1211118A (en) | 1982-03-26 | 1985-07-30 | 7-oxo-4-thia-1-azabicyclo[3,2,0]heptane derivatives |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000487761A Division CA1211118A (en) | 1982-03-26 | 1985-07-30 | 7-oxo-4-thia-1-azabicyclo[3,2,0]heptane derivatives |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000487761A Division CA1211118A (en) | 1982-03-26 | 1985-07-30 | 7-oxo-4-thia-1-azabicyclo[3,2,0]heptane derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1211118A true CA1211118A (en) | 1986-09-09 |
Family
ID=25669981
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000487762A Expired CA1210772A (en) | 1982-03-26 | 1985-07-30 | 7-oxo-4-thia-1-azabicyclo[3,2,0]heptane derivatives |
| CA000487761A Expired CA1211118A (en) | 1982-03-26 | 1985-07-30 | 7-oxo-4-thia-1-azabicyclo[3,2,0]heptane derivatives |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000487762A Expired CA1210772A (en) | 1982-03-26 | 1985-07-30 | 7-oxo-4-thia-1-azabicyclo[3,2,0]heptane derivatives |
Country Status (1)
| Country | Link |
|---|---|
| CA (2) | CA1210772A (en) |
-
1985
- 1985-07-30 CA CA000487762A patent/CA1210772A/en not_active Expired
- 1985-07-30 CA CA000487761A patent/CA1211118A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CA1210772A (en) | 1986-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR910002098B1 (en) | Process for preparing penem compound | |
| EP0078026B1 (en) | Antibiotic synthesis | |
| EP0294934B1 (en) | Diastereomeric 5R,6S-6-(1R-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids | |
| EP0069377B1 (en) | Antibacterial penem derivatives | |
| JPS62246550A (en) | 3,4-disubstituted-2-azetidinone derivative and production thereof | |
| KR900001170B1 (en) | A preparation process for 4-acetoxy-3-hydroxyl ethyl-azetizin-2-one derivatives | |
| AU634876B2 (en) | Novel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them | |
| CA2429346A1 (en) | 1-methylcarbapenem derivatives | |
| CA1246546A (en) | 2-alkylthiopenem derivatives | |
| CA1211118A (en) | 7-oxo-4-thia-1-azabicyclo[3,2,0]heptane derivatives | |
| JPH10507185A (en) | 2- (Imidazol-4-yl) carbapenem derivatives, their intermediates and use as antibacterial agents | |
| US4675396A (en) | 7-Oxo-4-thia-1-azabicyclo(3,2,0)heptane derivatives | |
| KR870001066B1 (en) | Method of manufacturing penem derivatives | |
| NZ199487A (en) | Azabicycloheptene derivatives,intermediates and pharmaceutical compositions | |
| NO841108L (en) | ANTIBACTERIAL PENEMDERIVATIVES. | |
| EP0632037B1 (en) | Process for the production of 4-substituted azetidinone derivatives | |
| CN101172962B (en) | Synthetic intermediate of carbapenem compound for oral administration | |
| US4841043A (en) | Stereoselective synthesis of 1-β-alkyl carbapenem antibiotic intermediates | |
| CA1212112A (en) | 4-cyano-2-azetidinones and production thereof | |
| US6265396B1 (en) | β-lactam compounds and process for preparing the same | |
| PL171733B1 (en) | Preparation of 2-substituted 3-carboxy-carbapenems | |
| GB2164334A (en) | Antibacterial 7-oxo-4-thia-1-azabicyclo(3,2,0)hept-2-ene derivatives | |
| KR100289512B1 (en) | Method for preparing beta-lactam compound and intermediates thereof | |
| JPS6118779A (en) | Carbapenems | |
| KR20050086548A (en) | Process for producing carbapenem compound for oral administration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |